Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3034780	fs-ace	u/l (u/l)	14389	28448	0.06%
3034780	fs-ace	— (—)	1829	2797	100.00%	Distribution not available
3034780	s-ace	u/l (u/l)	1403	2204	0.18%
3034780	s-ace	— (—)	637	717	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Anaemias

986

1545

4.40

323.31

2.0

39.61

41.11

u/l

1.11

893

1492

Other specified/unspecified arthritis

1266

4000

3.38

321.47

1.8

1.9

37.10

39.29

u/l

3.44

1142

3548

Reimbursement for rheumatic diseases

2330

10003

2.43

320.88

1.7

2.0

37.66

39.74

u/l

5.49

2117

8874

Medical observation and evaluation for suspected diseases and conditions

2441

5113

2.52

315.08

2.1

1.9

39.71

39.15

u/l

0.57

2187

4542

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

1242

1681

3.83

312.98

2.0

1.7

39.28

38.61

u/l

0.46

1132

1520

Renal tubulo-interstitial diseases

3230

11696

2.13

309.92

2.2

1.9

39.17

39.35

u/l

0.16

2835

10433

Anterior Iridocyclitis

1298

3125

4.66

307.65

2.4

2.0

39.35

39.22

u/l

0.07

1207

2778

Asthma (mode)

3145

5147

3.42

307.65

2.2

1.2

39.06

38.50

u/l

0.67

2848

4508

Excluding asthma or asthma-COPD overlap

2992

5160

3.01

307.65

2.3

1.2

39.56

38.49

u/l

1.79

2721

4524

Other systemic involvement of connective tissue (FG)

1283

3514

3.89

307.65

1.7

2.0

37.95

39.56

u/l

1.92

1154

3090

Asthma

3188

5103

3.42

307.65

2.1

1.2

39.10

38.47

u/l

0.78

2885

4471

Chronic kidney disease

1434

3925

3.86

307.65

2.5

1.7

39.45

38.02

u/l

1.47

1244

3340

Asthma, unspecified (mode)

2216

4743

3.70

307.65

2.2

1.2

38.79

38.32

u/l

0.43

1983

4132

Asthma, excluding more controls

3109

4638

3.66

307.65

2.2

1.2

39.09

38.93

u/l

0.14

2823

4152

Fever of other and unknown origin

2622

7127

3.47

307.65

2.0

1.8

38.84

39.16

u/l

0.30

2380

6304

Polyarthropathies

2909

7289

2.73

307.65

1.9

2.0

37.98

39.51

u/l

3.24

2595

6532

Autoimmune diseases

4179

9811

2.23

307.65

1.9

2.0

39.14

39.44

u/l

0.37

3800

8713

Other heart diseases, wide

3808

9907

2.44

307.65

2.4

1.9

38.43

40.37

u/l

6.04

3310

9140

Sarcoidosis

2996

1726

35.27

307.65

5.5

1.2

45.33

38.53

u/l

26.53

2856

1499

All chronic kidney diseases

2295

6919

2.85

307.65

2.3

1.8

38.64

39.17

u/l

0.51

2006

6091

Autoimmune diseases related-to ILD

3380

12961

2.32

307.65

1.8

2.0

38.00

39.85

u/l

6.14

3050

11536

General symptoms and signs

4441

8808

2.62

307.65

2.2

1.8

39.65

39.40

u/l

0.30

4008

7856

Other specific joint derangements/joint disorders

2875

8070

2.39

307.65

2.2

2.0

39.67

39.53

u/l

0.13

2597

7283

Renal failure

2011

5888

3.21

307.65

2.4

1.7

39.22

38.58

u/l

0.58

1745

5075

Other arthritis (FG)

1457

4615

3.37

307.65

1.8

2.0

37.27

39.78

u/l

4.91

1315

4102

ILD, hospital admissions 1, main diag only

821

1810

5.14

307.65

1.8

38.98

38.34

u/l

0.33

746

1543

Iridocyclitis

1470

3497

4.71

307.65

2.4

1.9

39.37

38.99

u/l

0.30

1364

3083

Polyneuropathies and other disorders of the peripheral nervous system

1182

3124

4.17

307.65

1.7

1.8

39.94

38.56

u/l

1.31

1035

2707

Other interstitial pulmonary diseases

891

2040

4.90

307.65

1.8

38.91

38.45

u/l

0.23

812

1746

Heart failure,strict

2044

5561

2.72

307.65

1.9

1.8

35.49

39.37

u/l

10.01

1595

4921

Other systemic involvement of connective tissue

1307

4171

3.37

307.65

1.7

2.0

38.22

39.04

u/l

0.72

1175

3653

Headache

2412

8038

2.48

307.65

2.1

1.8

39.09

39.40

u/l

0.31

2190

7175

Asthma, unspecified (mode), excluding more controls

2180

4313

3.98

307.65

2.2

1.2

38.79

u/l

0.00

1958

3839

Autoimmune diseases excluding thyroid diseases, strict definition

4303

9449

2.59

307.65

1.9

2.0

38.82

39.50

u/l

1.19

3893

8387

Systemic connective tissue disorders

1808

5490

3.56

307.65

1.7

1.9

37.53

39.29

u/l

3.10

1634

4804

All kidney diseases

3693

12502

2.08

307.65

2.2

1.9

38.79

39.60

u/l

1.34

3260

11228

L04AX Other immunosuppressants

2686

9737

2.93

307.65

2.6

1.9

37.43

39.86

u/l

7.62

2474

8647

Other and unspecified polyneuropathies, also in other diseases

1104

2678

4.60

307.65

1.8

40.03

38.40

u/l

1.59

965

2321

ILD differential diagnosis

2985

5147

3.01

307.65

2.3

1.2

39.56

38.50

u/l

1.74

2719

4508

Other pulmonary diagnosis

2771

5160

2.78

307.65

2.0

1.2

38.92

38.49

u/l

0.46

2515

4524

ILD, hospital admissions

884

2022

4.91

307.65

1.8

38.94

38.37

u/l

0.30

805

1731

Heart failure and antihypertensive medication

1252

2101

4.20

307.65

2.2

1.9

35.16

42.55

u/l

19.69

983

1978

ILD medications

5805

9274

3.59

307.65

2.6

1.5

38.36

40.13

u/l

6.88

5321

8182

ILD medications: immunosuppressive drugs

3310

8311

3.96

307.65

2.5

1.5

37.70

40.23

u/l

8.95

3041

7345

Inflammatory bowel disease treatment related agents

5767

10292

3.31

307.65

2.7

1.5

38.55

40.00

u/l

4.92

5260

9117

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

576

992

6.83

307.65

1.7

1.8

36.53

38.25

u/l

0.98

503

861

Cardiomyopathy

933

2183

4.69

307.65

2.4

1.7

33.39

39.25

u/l

10.29

681

1965

Acute and subacute iridocyclitis

1204

2893

4.65

307.65

2.3

2.0

39.50

38.99

u/l

0.37

1123

2570

Cardiac arrhythmias

2391

6433

2.51

307.65

2.5

1.9

39.22

40.86

u/l

3.07

2101

6044

Autoimmune diseases excluding thyroid diseases

4462

9771

2.59

307.65

1.9

2.0

38.81

39.42

u/l

1.03

4033

8676

Heart failure, not strict

3001

8455

2.52

307.65

2.2

1.9

36.87

40.06

u/l

10.95

2464

7595

Oral corticosteroids

5650

10048

3.54

307.65

2.8

1.5

38.46

39.97

u/l

5.19

5147

8885

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

802

589

11.06

307.65

1.9

2.2

38.73

41.07

u/l

1.47

737

532

Cough

1714

5535

3.08

307.65

2.3

1.8

40.64

39.29

u/l

1.89

1550

4924

ILD medications: prednisolone, methylprednisolone, prednisone

5647

9155

3.66

307.65

2.8

1.5

38.64

40.12

u/l

4.84

5165

8071

Other heart diseases

2238

4609

3.35

307.65

2.6

1.9

38.13

41.41

u/l

9.19

1944

4365

Diagnoses used for exclusion with ILD

3293

3431

12.71

307.65

5.1

1.2

44.74

37.83

u/l

38.97

3120

2929

Abnormal findings on diagnostic imaging of lung

3107

6553

5.06

307.65

2.9

1.7

40.69

38.58

u/l

5.24

2834

5612

Symptoms and signs involving the circulatory and respiratory systems

3714

8533

2.25

307.65

2.1

1.9

39.21

39.47

u/l

0.30

3358

7719

Second line medication for Crohn's disease

2747

10020

2.91

307.65

2.6

1.9

37.52

39.84

u/l

7.14

2531

8899

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

5948

10330

4.29

307.65

3.4

1.2

42.14

37.87

u/l

33.81

5405

9127

Abnormalities of breathing

3725

8509

2.64

307.65

2.2

1.9

39.39

39.48

u/l

0.08

3318

7695

Myocarditis

465

518

11.13

307.65

6.9

1.8

36.66

42.30

u/l

5.06

431

483

Asthma (diagnoses ohter than nonallergic)

3318

13311

2.14

307.65

2.1

1.9

38.85

39.45

u/l

0.92

2995

11849

Used for control exclusion in common control thyroid runs

3906

8988

2.26

307.65

1.9

2.0

38.94

39.56

u/l

0.96

3561

7974

Certain disorders involving the immune mechanism

3295

2583

20.06

307.65

5.2

1.2

44.62

38.40

u/l

29.11

3128

2258

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

3937

9004

4.27

307.65

2.7

1.7

40.45

38.82

u/l

4.29

3581

7814

Finngen Rheumatological endpoints

3613

9764

2.17

307.65

1.9

2.1

38.40

40.03

u/l

4.74

3261

8795

Interstitial lung disease

891

2049

4.88

307.65

1.8

38.91

38.43

u/l

0.25

812

1752

Asthma (only as main-diagnosis)

2882

5103

3.42

307.65

2.1

1.2

38.74

38.47

u/l

0.25

2609

4471

Enlarged lymph nodes

1401

1945

8.55

307.65

3.4

1.8

43.09

38.86

u/l

7.81

1314

1720

First line medication for Crohn's disease

5315

9230

3.27

307.65

2.6

1.5

38.45

40.07

u/l

5.60

4864

8166

COPD differential diagnosis

2985

5150

3.01

307.65

2.3

1.2

39.57

38.50

u/l

1.79

2719

4511

Interstitial lung disease endpoints

891

2049

4.88

307.65

1.8

38.91

38.43

u/l

0.25

812

1752

Dyspnoea

3717

11836

2.42

307.65

2.1

2.0

39.00

39.41

u/l

0.52

3252

10573

Pain in joint

2441

5997

2.71

307.65

2.2

2.0

39.50

39.78

u/l

0.26

2193

5317

Disorders of sclera, cornea, iris and ciliary body

2453

9491

2.73

307.65

2.2

2.0

39.42

39.30

u/l

0.10

2263

8416

Asthma (only as main-diagnosis), excluding more controls

2832

4638

3.65

307.65

2.1

1.2

38.72

38.93

u/l

0.19

2571

4152

Other respiratory diseases principally affecting the interstitium

995

2391

4.61

307.65

1.8

38.57

38.53

u/l

0.02

900

2046

Other soft tissue disorders, not elsewhere classified

3417

9842

2.10

300.69

1.9

2.0

39.19

39.27

u/l

0.08

3075

8810

Pain in throat and chest

2962

8284

2.21

300.23

2.1

1.9

38.77

39.58

u/l

1.21

2650

7476

Disorders of calcium metabolism

483

794

7.23

290.67

3.1

1.8

41.01

39.57

u/l

0.58

424

702

Malaise and fatigue

1817

5746

2.64

290.40

1.8

38.28

38.93

u/l

0.63

1571

5047

Bacterial infection, other or unspecified

2177

7928

2.42

289.93

1.8

1.9

37.40

39.43

u/l

4.01

1877

6958

Cardiovascular diseases (excluding rheumatic etc)

2344

5792

2.40

283.58

2.3

1.9

38.27

41.05

u/l

7.79

2109

5507

Bacterial infection, other or unspecified

2022

7421

2.47

282.27

1.8

1.9

37.44

39.34

u/l

3.33

1742

6496

Heart failure, strict

2141

6437

2.45

280.53

1.9

1.8

35.48

39.24

u/l

10.00

1670

5650

Disorders of mineral metabolism

559

1087

5.91

280.14

2.9

1.9

41.13

39.54

u/l

0.77

491

965

Chronic iridocyclitis

427

647

8.11

279.74

2.9

1.9

38.15

39.21

u/l

0.45

398

571

Any gastric operation

2749

6293

2.25

277.36

2.0

1.9

39.83

39.21

u/l

0.78

2510

5653

GASTRO-related operations

2749

6293

2.25

277.36

2.0

1.9

39.83

39.21

u/l

0.78

2510

5653

Asthma-related infections

2197

9637

2.32

274.32

2.1

1.9

38.07

39.55

u/l

2.71

1951

8534

Asthma, hospital admission 2, infections

2197

9637

2.32

274.32

2.1

1.9

38.07

39.55

u/l

2.71

1951

8534

Symptoms and signs involving the skin and subcutaneous tissue

2645

12557

2.14

269.90

2.0

39.58

39.25

u/l

0.36

2404

11137

Infections, IBD-co-morbidities

651

946

5.21

267.77

1.8

2.3

38.49

41.54

u/l

2.49

572

870

Implicit Sepsis

2938

10677

2.08

264.38

2.0

1.9

38.53

39.62

u/l

1.88

2578

9486

All-cause Heart Failure

2071

6320

2.41

262.95

1.9

1.8

35.45

39.24

u/l

10.03

1616

5550

3168

9685

2.04

261.06

2.1

1.9

38.60

39.98

u/l

3.02

2830

8662

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3168

9685

2.04

261.06

2.1

1.9

38.60

39.98

u/l

3.02

2830

8662

Chronic lower respiratory diseases

4225

12398

1.86

260.03

2.1

2.0

39.03

39.59

u/l

0.93

3818

11062

Other bacterial diseases

3356

11762

1.97

258.99

2.0

38.54

39.74

u/l

2.31

2942

10504

Other bacterial diseases

3584

12069

1.94

258.76

1.9

2.0

38.45

39.88

u/l

3.36

3156

10840

Asthma, hospital admissions , main diagnosis only

2983

13457

2.02

257.23

2.1

1.9

38.64

39.55

u/l

1.65

2695

12000

Abnormal findings on examination of blood, without diagnosis

1803

6988

2.48

256.61

1.8

1.9

40.27

38.26

u/l

3.11

1585

6101

ILD medications: azathioprine

686

1673

4.43

256.37

3.7

1.4

37.34

39.93

u/l

2.44

632

1472

Implicit Sepsis

2691

9917

2.11

255.77

2.0

1.9

38.41

39.47

u/l

1.66

2358

8773

ILD, hospital admission 2, with pulmonary infections

541

1107

5.46

253.88

1.8

38.50

38.70

u/l

0.07

492

930

Cardiovascular diseases

2146

4976

2.39

252.00

2.1

1.9

38.64

40.89

u/l

5.17

1954

4753

Condition for Implicit Sepsis (Organ dysfunction codes)

3036

10937

2.02

251.90

2.0

1.9

38.65

39.68

u/l

1.74

2661

9749

Conduction disorders

1175

3228

3.11

250.21

2.9

1.7

37.38

39.76

u/l

3.00

991

2878

Condition for Implicit Sepsis (Organ dysfunction codes)

3183

11393

1.98

250.01

2.1

2.0

38.88

39.75

u/l

1.41

2790

10207

Neurological diseases, wide definition

1035

1452

3.70

249.60

1.9

2.2

38.76

41.32

u/l

2.91

952

1346

Asthma, including avohilmo

4096

12889

1.83

242.05

2.0

39.09

39.49

u/l

0.58

3704

11483

Hypercalcemia

367

562

8.16

239.05

3.3

1.9

40.47

39.30

u/l

0.36

325

489

Examination and observation for other reasons

2015

5083

2.36

236.14

2.0

1.9

39.62

39.18

u/l

0.36

1806

4517

Hypertensive diseases (excluding secondary)

1885

4652

2.44

235.04

2.1

1.9

38.35

41.39

u/l

7.37

1668

4403

Cardiomyopathies, Primary/intrinsic

612

1471

4.56

234.41

2.0

1.7

31.85

39.37

u/l

10.37

411

1314

1676

7154

2.42

231.13

2.1

1.9

38.36

39.65

u/l

1.75

1502

6386

Azathioprine

686

1814

4.08

229.50

3.7

1.5

37.34

39.80

u/l

2.26

632

1605

Influenza and pneumonia

3649

12871

1.85

229.39

2.1

2.0

38.72

39.79

u/l

2.23

3244

11577

Neurological diseases

2878

7251

2.04

229.37

1.9

2.0

38.59

39.94

u/l

2.79

2587

6488

Chorioretinal inflammation

300

392

10.09

226.81

2.9

1.9

41.27

38.42

u/l

1.21

279

350

Pain in limb

2789

9564

2.01

225.58

2.0

39.17

39.28

u/l

0.10

2508

8548

Persons encountering health services for specific procedures and health care

3726

12490

1.83

225.29

2.2

1.9

38.80

39.62

u/l

1.49

3309

11237

Other diseases of pleura

1616

6033

2.45

222.96

1.7

1.8

36.70

38.85

u/l

3.66

1412

5193

Cardiomyopathy (excluding other)

617

1558

4.32

221.07

2.0

1.7

31.80

39.37

u/l

10.61

415

1396

Pneumonias (Asthma/COPD co-morbidities)

3464

12892

1.85

220.93

2.1

2.0

38.61

39.82

u/l

2.67

3081

11566

Other arrhythmias

2216

8020

2.15

220.89

2.4

1.9

38.76

40.15

u/l

2.42

1932

7330

Other disorders of lacrimal gland

1414

5784

2.57

220.27

2.6

1.9

40.13

39.28

u/l

0.81

1286

5089

Pneumonia, organism unspecified

3145

11922

1.90

219.19

2.0

38.41

39.84

u/l

3.25

2782

10670

All pneumoniae

3477

12936

1.84

218.51

2.1

2.0

38.64

39.80

u/l

2.52

3089

11616

AV-block

723

1758

3.83

216.47

3.3

1.6

37.25

38.73

u/l

0.98

625

1540

Symptoms and signs involving the nervous and musculoskeletal systems

2086

10125

2.13

213.47

1.8

2.0

38.90

39.29

u/l

0.40

1892

8931

Oedema, not elsewhere classified

1124

4107

2.82

212.30

2.0

1.7

40.74

38.91

u/l

1.92

978

3581

Obesity related asthma

1370

5634

2.56

210.78

2.2

1.9

38.38

39.43

u/l

1.09

1236

4992

Hard cardiovascular diseases

2898

9134

1.95

209.50

2.3

2.0

37.81

40.46

u/l

8.28

2458

8296

Disorders of lacrimal system

1629

7222

2.35

209.39

2.5

1.9

39.99

39.37

u/l

0.58

1480

6356

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3369

12861

1.83

208.88

2.1

2.0

38.54

39.82

u/l

2.89

2987

11537

Other special examinations and investigations of persons without complaint or reported diagnosis

2167

5113

2.20

208.85

2.0

1.9

39.12

39.15

u/l

0.02

1966

4542

Percutaneous Coronary Intervention

2726

8696

1.98

207.77

2.3

2.0

38.04

40.31

u/l

5.74

2289

7833

Disturbances of skin sensation

1191

4633

2.72

206.54

1.9

2.0

39.07

39.25

u/l

0.11

1096

4171

Coronary revascularization (ANGIO or CABG)

2722

8697

1.97

205.74

2.3

2.0

38.07

40.30

u/l

5.61

2285

7834

Ischemic heart diseases

2845

9087

1.94

202.29

2.3

2.0

37.68

40.35

u/l

8.31

2408

8204

Diseases of liver

1368

5740

2.50

201.53

2.0

44.39

38.80

u/l

13.60

1229

5070

Heart failure and coronary heart disease

1476

4378

2.49

201.51

1.9

1.7

35.07

39.23

u/l

8.56

1123

3813

Emergency coronary revascularization (for ACS)

2878

9368

1.92

200.89

2.3

1.9

38.00

40.14

u/l

5.46

2413

8394

Diseases of the eye and adnexa

2696

6960

1.99

199.11

2.1

1.9

39.56

39.32

u/l

0.23

2497

6250

Nonischemic cardiomyopathy

522

1266

4.56

198.19

2.0

1.9

33.01

39.65

u/l

6.63

361

1118

Disorders of other endocrine glands

1607

7189

2.29

194.30

1.9

39.61

39.38

u/l

0.16

1411

6407

Tramadol

2728

8928

1.93

193.46

1.9

2.0

39.61

39.50

u/l

0.10

2409

8001

Acute renal failure

851

2871

3.15

193.22

2.3

1.7

38.61

38.51

u/l

0.04

745

2457

Disorders of thyroid, IBD co-morbidities

610

1083

4.13

191.98

2.2

38.26

41.65

u/l

3.09

546

992

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3258

12020

1.81

191.96

2.3

1.9

38.78

39.61

u/l

1.35

2868

10823

Major coronary heart disease event

2819

9245

1.89

187.83

2.3

2.0

38.07

40.24

u/l

5.51

2367

8310

Pacemaker

1136

4308

2.65

187.47

2.7

1.7

36.82

38.43

u/l

1.57

937

3645

Implicit bacterial Sepsis

1531

5925

2.32

186.82

1.9

1.8

38.03

39.11

u/l

1.06

1311

5144

Visual disturbances and blindness

1831

8921

2.13

185.65

1.9

39.06

39.28

u/l

0.18

1631

7881

Any reimbursement code in KELA

1904

4428

2.21

184.89

1.9

2.1

38.55

40.95

u/l

5.42

1742

4109

Disorders of eyelid, lacrimal system and orbit

2867

12129

1.84

184.79

2.2

1.9

39.41

39.26

u/l

0.13

2574

10756

Bacterial Sepsis

1583

6175

2.27

184.23

1.9

1.8

38.08

39.07

u/l

0.97

1357

5375

Metabolic disorders

3176

11003

1.80

183.43

2.1

2.0

38.37

39.84

u/l

3.31

2773

9922

Implicit bacterial Sepsis

1409

5463

2.38

183.05

1.9

1.8

38.11

39.04

u/l

0.80

1205

4740

Diseases of oesophagus, stomach and duodenum

3527

12343

1.75

182.41

1.9

2.0

39.69

39.31

u/l

0.46

3145

11056

Non-ischemic cardiomyopathy

1120

3536

2.68

181.35

1.9

1.8

35.09

39.52

u/l

7.48

868

3104

Adjustment and management of implanted device

723

2308

3.33

180.50

3.5

1.7

37.37

38.35

u/l

0.52

581

1961

Abnormalities of heart beat

1194

4833

2.51

179.78

2.2

1.8

39.51

38.93

u/l

0.42

1071

4278

Undetermined asthma, excluding more controls

477

1159

4.36

178.01

1.9

1.2

37.46

38.87

u/l

0.71

416

1014

Atrial fibrillation and flutter

1109

2748

2.72

177.71

2.3

1.9

39.07

42.03

u/l

3.88

949

2572

COPD/asthma related infections

3365

9686

1.78

177.36

2.0

1.9

38.56

39.99

u/l

3.52

3012

8663

COPD/asthma/ILD related infections

3365

9686

1.78

177.36

2.0

1.9

38.56

39.99

u/l

3.52

3012

8663

ILD, hospital admissions 3, with pneumonia sepsis

433

997

4.81

176.05

1.7

37.63

38.35

u/l

0.27

393

849

Dorsalgia

3260

10026

1.78

175.42

1.9

2.0

39.61

39.20

u/l

0.51

2935

8962

Other necrotizing vasculopathies (FG)

349

676

5.85

175.26

1.6

2.0

33.34

39.17

u/l

6.22

320

592

Other and unspecified iridocyclitis

325

597

6.41

174.61

2.1

2.0

39.15

39.09

u/l

0.02

302

526

Hypertension, essential

2637

8088

1.89

174.34

2.1

38.48

40.68

u/l

5.55

2324

7434

Visual disturbances

1706

8316

2.13

173.17

1.9

39.04

39.17

u/l

0.09

1528

7353

Sleep apnoea

3149

11794

1.77

173.06

2.2

2.0

39.47

39.53

u/l

0.06

2798

10519

Paroxysmal tachycardia

824

2378

3.04

171.28

2.8

1.8

37.37

41.47

u/l

6.25

720

2219

Other joint disorders

2818

8230

1.84

170.08

2.0

39.70

39.51

u/l

0.18

2547

7420

Non-allergic asthma (mode), excluding more controls

590

1700

3.59

168.90

2.1

1.2

39.89

39.03

u/l

0.43

527

1474

Episodal and paroxysmal disorders

3519

10584

1.73

168.73

2.0

1.9

38.99

39.61

u/l

0.96

3175

9434

Pain, not elsewhere classified

953

3659

2.71

168.14

1.9

1.8

38.47

39.05

u/l

0.39

868

3261

Arthropathies

2905

8235

1.82

167.80

1.9

2.0

39.05

39.50

u/l

0.55

2638

7425

Cardiomyopathy, other and unspecified

405

920

4.87

167.55

3.2

1.7

33.83

39.67

u/l

5.10

311

821

Implicit viral Sepsis

1040

4209

2.58

165.06

2.2

1.8

38.66

39.05

u/l

0.22

918

3685

Low back pain

2485

9813

1.86

164.90

1.9

2.0

39.74

39.19

u/l

0.64

2232

8764

Undetermined asthma

477

1231

4.10

164.03

1.9

1.2

37.46

38.55

u/l

0.50

416

1051

Nerve, nerve root and plexus disorders

3476

12801

1.70

163.72

2.0

39.94

39.25

u/l

1.11

3109

11392

Other necrotizing vasculopathies

398

913

4.90

163.56

1.7

1.8

33.28

38.59

u/l

6.39

362

795

Certain infectious and parasitic diseases

3134

9046

1.77

163.51

2.0

39.19

39.52

u/l

0.37

2796

8154

Aplastic and other anaemias

1504

6627

2.19

163.12

1.7

1.8

39.12

38.61

u/l

0.34

1285

5740

Sleep apnoea, including avohilmo

3269

12017

1.72

162.19

2.2

2.0

39.59

39.52

u/l

0.06

2904

10740

Atrial fibrillation and flutter with reimbursement

908

2082

2.90

161.63

2.3

1.8

38.12

41.78

u/l

4.77

765

1935

Other and unspecified dermatitis

1783

9047

2.04

161.56

2.1

2.0

39.76

39.38

u/l

0.33

1606

8031

Dermatitis

2056

10929

1.93

160.01

2.1

2.0

39.53

39.30

u/l

0.20

1853

9680

Dilated cardiomyopathy

560

1657

3.69

159.94

1.9

1.8

30.90

38.70

u/l

10.89

368

1441

Diseases of the respiratory system

1985

4980

2.04

158.79

1.9

39.05

40.05

u/l

1.26

1795

4407

Other anaemias

1399

6208

2.22

157.32

1.7

1.8

39.11

38.58

u/l

0.33

1190

5372

Other symptoms and signs involving the nervous and musculoskeletal systems

1492

7176

2.16

157.03

1.9

2.0

38.83

39.15

u/l

0.26

1378

6373

Other and unspecified anaemias

1387

6157

2.22

156.92

1.7

1.8

39.24

38.57

u/l

0.44

1179

5323

Asthma/COPD (KELA code 203)

3053

12378

1.73

156.32

2.0

38.24

39.58

u/l

3.15

2753

11044

Asthma-related pneumonia

1216

5389

2.34

156.08

2.1

1.8

38.14

39.29

u/l

1.10

1064

4673

Allergic asthma (mode), excluding more controls

705

2338

3.06

155.99

1.9

1.2

38.52

38.87

u/l

0.19

655

2119

Asthma-related pneumonia or sepsis

1217

5400

2.33

155.73

2.1

1.8

38.15

39.28

u/l

1.06

1065

4684

Asthma, hospital admissions 3, pneumonia

1217

5400

2.33

155.73

2.1

1.8

38.15

39.28

u/l

1.06

1065

4684

Codeine

3039

9628

1.75

155.63

2.0

39.39

39.50

u/l

0.11

2725

8662

Liquid cancers, helper endpoint

1340

5378

2.26

154.19

1.8

1.9

39.40

38.94

u/l

0.30

1185

4682

Non-invasive ventilation

831

2747

2.82

153.72

1.9

37.87

40.84

u/l

3.99

741

2541

Hypertensive diseases

2606

8261

1.82

153.53

2.1

38.62

40.65

u/l

4.84

2298

7594

Idiopathic pulmonary fibrosis

380

882

4.77

153.12

1.5

1.8

37.27

38.08

u/l

0.29

344

741

Hypertension

2601

8258

1.82

152.35

2.1

38.63

40.65

u/l

4.75

2294

7591

Opioids

3166

9732

1.72

151.96

1.9

2.0

39.13

39.48

u/l

0.43

2838

8761

Non-allergic asthma (mode)

590

1818

3.35

151.88

2.1

1.2

39.89

38.72

u/l

0.65

527

1545

Hypothyroidism (congenital or acquired)

840

1659

2.95

150.82

2.0

39.54

40.93

u/l

1.14

778

1600

Gout

906

3115

2.67

150.38

1.9

1.8

37.33

38.49

u/l

0.79

770

2672

Pleural effusion

611

1972

3.30

150.18

1.6

1.7

36.36

38.79

u/l

1.89

524

1686

Heart failure and bmi 25plus

1204

3535

2.40

149.94

1.9

2.0

35.22

38.80

u/l

5.65

929

3089

L04AA Selective immunosuppressants

925

3728

2.62

149.51

1.9

2.0

38.06

39.62

u/l

1.49

843

3343

Soft tissue disorders

3227

9929

1.71

149.02

1.9

2.0

39.24

39.30

u/l

0.05

2896

8891

Syncope and collapse

1327

5278

2.21

147.14

2.0

1.8

38.66

38.78

u/l

0.07

1155

4610

Antihypertensive medication - note that there are other indications

1937

5277

1.99

146.63

2.0

1.9

38.46

41.17

u/l

6.75

1745

5041

Hypothyroidism and >3 levothyroxin purchases

829

1654

2.92

146.53

2.0

39.61

40.94

u/l

1.05

768

1595

Hypothyroidism, levothyroxine purchases

829

1654

2.92

146.53

2.0

39.61

40.94

u/l

1.05

768

1595

Erythema nodosum

239

390

7.47

146.01

2.9

2.1

40.62

39.44

u/l

0.35

219

351

Dermatitis and eczema

3527

13616

1.64

144.96

2.0

39.53

39.36

u/l

0.19

3190

12126

Presence of cardiac and vascular implants and grafts

1409

4976

2.18

144.07

2.8

1.8

37.18

38.68

u/l

1.64

1150

4283

Endocrine, nutritional and metabolic diseases

2545

7271

1.81

143.11

2.0

39.39

39.95

u/l

0.64

2289

6695

3570

11450

1.64

142.67

2.0

1.9

38.91

39.69

u/l

1.37

3197

10197

Disorders of parathyroid gland

779

2910

2.79

142.61

1.8

1.9

38.99

39.22

u/l

0.11

658

2523

General examination and investigation of persons without complaint and reported diagnosis

1900

5112

1.98

141.74

2.0

1.9

40.32

39.16

u/l

1.39

1733

4541

Allergic asthma (mode)

705

2469

2.89

141.37

1.9

1.2

38.52

38.60

u/l

0.04

655

2189

Haemorrhage from respiratory passages

1048

4132

2.36

136.32

1.8

38.78

38.66

u/l

0.06

900

3591

Unspecified kidney failure

420

1139

3.97

135.85

2.7

1.7

40.65

38.01

u/l

1.45

375

962

Gastro-oesophageal reflux disease

2184

10689

1.81

135.76

1.9

2.0

39.53

39.27

u/l

0.24

1942

9523

Lower back pain or/and sciatica

3341

13714

1.62

133.75

1.9

2.0

39.65

39.31

u/l

0.41

3001

12235

Other dorsopathies, not elsewhere classified

3142

10057

1.67

133.54

1.9

2.0

39.44

39.19

u/l

0.27

2825

8992

Persons encountering health services in other circumstances, wide

3657

11954

1.60

133.14

2.0

39.29

39.39

u/l

0.11

3272

10639

Codeine or tramadol medication

3585

12449

1.60

132.73

2.0

39.18

39.39

u/l

0.24

3182

11149

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3483

11937

1.61

132.21

2.0

39.34

39.41

u/l

0.06

3134

10628

Migraine

1640

6953

1.97

130.77

2.1

1.9

38.10

39.70

u/l

2.81

1537

6306

Cerebrovascular diseases (FINNGEN)

1000

3017

2.43

130.62

1.8

1.9

37.86

41.81

u/l

6.59

850

2827

Diseases of the musculoskeletal system and connective tissue

1606

4007

2.05

130.55

1.9

2.0

38.89

39.57

u/l

0.63

1465

3619

Diseases of the skin and subcutaneous tissue

3127

9620

1.66

130.08

2.0

1.9

39.71

39.13

u/l

0.78

2803

8589

Viral Sepsis

724

2772

2.74

129.34

2.3

1.8

38.22

39.12

u/l

0.48

647

2431

Implicit viral Sepsis

722

2769

2.74

128.55

2.3

1.8

38.27

39.12

u/l

0.45

645

2429

Polymyalgia rheumatica

505

1598

3.37

128.45

1.4

1.8

34.06

38.42

u/l

5.18

445

1345

Other diseases of intestines

3327

11925

1.62

127.84

2.0

39.25

39.52

u/l

0.31

2985

10721

Demyelinating diseases of the central nervous system

442

1305

3.71

126.98

1.4

2.1

36.35

39.52

u/l

2.91

416

1199

Eosinophilic disease (BM)

127

112

14.15

126.74

1.6

1.2

42.61

40.81

u/l

0.27

118

Glomerular diseases

702

2686

2.77

126.30

1.7

1.9

38.33

38.84

u/l

0.23

603

2362

Other diseases of liver

730

2856

2.71

125.73

2.0

43.09

39.13

u/l

5.05

652

2538

Persons encountering health services for examination and investigation

1904

5113

1.90

125.69

1.9

39.20

39.15

u/l

0.03

1713

4542

Pain (limb, back, neck, head abdominally)

2181

6134

1.81

124.23

1.9

2.0

39.10

39.66

u/l

0.58

1958

5420

Hyperparathyroidism

672

2508

2.79

123.51

1.8

1.9

38.82

39.09

u/l

0.12

570

2167

Spondylopathies

2444

8615

1.73

122.94

1.9

2.0

39.19

39.24

u/l

0.04

2167

7631

Primary_lymphoid and hematopoietic malignant neoplasms

837

3519

2.49

122.87

1.7

1.8

40.34

38.63

u/l

1.31

754

3021

Urticaria and erythema

1257

6225

2.09

122.39

2.1

2.0

41.17

39.25

u/l

2.80

1138

5599

Hypothyroidism, strict autoimmune

2086

7793

1.80

121.99

2.0

39.89

39.31

u/l

0.63

1888

6888

Gout, FINNGEN

906

3941

2.38

121.61

1.9

1.7

37.33

38.44

u/l

0.78

770

3357

Symptoms and signs involving cognition, perception, emotional state and behaviour

3021

12975

1.62

120.81

1.9

2.0

38.82

39.52

u/l

1.08

2680

11605

Dorsopathies

3160

10077

1.62

120.47

1.9

2.0

39.62

39.19

u/l

0.53

2840

9011

Scleritis

142

165

11.71

118.56

1.6

2.5

35.36

39.75

u/l

1.51

137

152

Parasetamol

2296

6739

1.76

118.06

1.9

2.0

38.98

40.10

u/l

1.72

2083

6105

Myalgia

841

3617

2.42

116.94

1.9

2.0

39.36

39.31

u/l

0.02

754

3250

Chronic sinusitis

1414

7416

1.96

116.05

2.1

2.0

38.98

39.74

u/l

0.75

1289

6627

Rheumatoid arthritis

1030

4299

2.22

115.55

1.6

2.0

37.90

39.32

u/l

1.41

916

3791

Other disorders of skin and subcutaneous tissue

2127

11162

1.73

115.21

2.1

1.9

40.15

39.10

u/l

1.49

1875

9861

Covid-19 confirmed case

1180

5842

2.09

114.91

1.9

36.99

39.17

u/l

3.36

1052

5121

Provisional assignment of new diseases of uncertain etiology

1673

9280

1.85

114.52

1.9

37.50

39.17

u/l

2.97

1505

8256

Codes for special purposes

1674

9290

1.85

114.41

1.9

37.51

39.16

u/l

2.95

1506

8266

Sulfasalazine

874

3860

2.34

113.65

1.6

1.5

36.93

39.64

u/l

4.05

775

3388

Depression medications

865

1764

2.53

113.24

1.9

2.0

39.90

41.22

u/l

1.00

798

1705

Scleritis and episcleritis

322

835

4.27

112.34

1.6

2.0

36.90

38.91

u/l

1.09

301

755

Other intervertebral disc disorders

2539

9351

1.67

111.60

2.0

39.98

39.27

u/l

0.94

2276

8334

Sicca syndrome [Sjögren]

393

1170

3.66

111.33

2.0

39.92

39.94

u/l

0.01

360

1037

Dialysis, with operation codes

501

1722

3.11

110.80

1.8

39.40

38.86

u/l

0.20

448

1504

Septicaemia

1244

5917

2.02

110.59

2.0

1.8

38.52

39.00

u/l

0.31

1082

5151

Symptoms and signs involving the digestive system and abdomen

3042

9682

1.60

109.86

1.9

2.0

39.29

39.64

u/l

0.39

2732

8620

Bronchitis

3270

13510

1.55

107.80

2.0

39.00

39.50

u/l

0.70

2935

12057

Explicit Sepsis

1299

6340

1.97

106.48

2.0

1.8

38.40

38.98

u/l

0.41

1134

5548

Sleep disorders (combined)

3407

11774

1.54

106.29

2.0

1.9

39.33

39.44

u/l

0.11

3017

10532

Continuous positive airway pressure

624

2028

2.70

105.31

2.5

1.9

37.67

41.02

u/l

3.56

525

1857

Other headache syndromes

1331

7070

1.93

104.92

2.0

39.81

39.72

u/l

0.05

1222

6324

Subjective visual disturbances

886

4083

2.26

104.81

2.0

1.9

39.43

38.97

u/l

0.29

796

3615

Care involving dialysis

355

1030

3.74

104.53

1.7

1.9

39.03

39.41

u/l

0.11

324

903

Valvular heart disease excluding rheumatic fever

1321

4962

1.97

104.51

1.9

1.8

38.57

40.11

u/l

1.66

1117

4446

Certain infectious and parasitic diseases

2214

6580

1.71

104.34

1.9

2.0

38.83

39.68

u/l

1.08

1950

5934

Non-rheumatic valve diseases

1315

4939

1.97

103.85

1.9

1.8

38.48

40.09

u/l

1.77

1112

4425

Acute upper respiratory infections

3132

12644

1.55

103.31

2.0

39.14

39.50

u/l

0.44

2834

11223

Disorders of optic nerve and visual pathways

422

1372

3.31

103.30

2.2

1.9

38.96

39.09

u/l

0.05

395

1241

Early onset COPD, excluding more controls

534

1955

2.83

103.20

2.0

1.2

38.36

38.00

u/l

0.14

456

1647

Other diseases of blood and blood-forming organs, wide

790

3503

2.36

102.92

1.9

41.45

39.01

u/l

2.02

700

3081

Fibromyalgia

402

1278

3.37

101.91

1.8

2.1

40.20

39.85

u/l

0.14

355

1184

Complications of surgical and medical care, not elsewhere classified

2992

13401

1.56

101.79

2.0

39.19

39.38

u/l

0.19

2659

11952

COPD (mode)

733

2416

2.45

101.41

1.7

1.2

37.68

37.70

u/l

0.01

618

2030

Disorders of choroid and retina

2389

10571

1.64

101.40

2.1

1.9

40.05

39.05

u/l

1.38

2091

9295

Gastrointestinal diseases

1775

4993

1.81

101.21

1.9

2.1

39.34

39.33

u/l

0.01

1610

4527

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1304

4276

1.97

100.46

2.2

1.9

40.16

41.32

u/l

1.15

1183

4045

Small fibre neuropathy

197

387

6.02

98.83

2.0

39.70

38.61

u/l

0.26

176

342

Dizziness and giddiness

2260

11132

1.64

98.54

2.0

39.11

39.29

u/l

0.16

1989

9888

MS-disease / Multiple Sclerosis

359

1093

3.58

98.32

1.4

2.1

36.21

39.79

u/l

2.98

337

999

Other septicaemia

1096

5362

2.02

97.89

2.0

1.8

38.42

39.01

u/l

0.36

955

4656

Hypothyroidism, drug reimbursement

453

1051

3.16

97.41

1.9

37.39

41.54

u/l

3.93

418

1011

Abdominal and pelvic pain

2965

9682

1.56

96.98

2.0

39.21

39.64

u/l

0.51

2663

8620

Other diseases of pericardium

221

482

5.08

96.41

1.8

1.6

35.12

39.67

u/l

2.08

188

424

Other nutritional deficiencies

2048

11845

1.66

96.39

2.0

38.73

39.46

u/l

0.88

1818

10652

Secondary hypertension

301

809

3.91

96.31

1.9

1.8

38.19

42.02

u/l

2.47

271

753

Osteopathies and chondropathies

1695

9244

1.75

95.77

2.3

1.9

39.64

39.41

u/l

0.17

1484

8178

Factors influencing health status and contact with health services

872

1929

2.32

95.61

2.0

1.8

38.82

39.14

u/l

0.16

771

1729

Vocal cord dysfunction

444

1361

3.05

95.53

1.9

2.1

38.08

41.06

u/l

2.40

393

1264

Erysipelas

2088

9772

1.66

95.46

2.0

38.74

39.70

u/l

1.15

1797

8660

Abnormal findings on diagnostic imaging of central nervous system

242

574

4.67

95.11

1.8

38.12

40.13

u/l

0.82

225

503

Glomerular disorders in diseases classified elsewhere

460

1643

2.99

95.00

1.8

1.9

39.19

38.89

u/l

0.09

394

1438

Other or ill-defined heart diseases

250

607

4.47

94.61

3.5

1.7

35.64

40.93

u/l

3.41

223

546

Acute sinusitis

1634

8796

1.76

94.44

2.1

2.0

39.00

39.71

u/l

0.72

1468

7922

Primary hyperparathyroidism

449

1594

3.02

94.12

1.6

1.9

38.48

39.72

u/l

0.63

375

1397

Symptoms and signs concerning food and fluid intake

362

1132

3.37

93.27

1.6

38.29

39.05

u/l

0.22

316

993

Other diseases of upper respiratory tract

3216

11210

1.52

93.10

1.9

39.10

39.51

u/l

0.54

2870

9958

Diseases of arteries, arterioles and capillaries (FINNGEN)

717

2122

2.42

92.80

1.9

38.73

41.80

u/l

3.01

614

1978

Other specified/unspecified systemic involvement of connective tissue

285

776

4.05

92.76

1.6

2.0

40.36

39.27

u/l

0.38

259

688

Mixed connective tissue disease

311

901

3.79

92.34

1.6

2.0

40.04

39.10

u/l

0.34

282

809

Gout, idiopatic and unspecified

771

3535

2.27

92.27

1.9

1.7

37.41

38.07

u/l

0.35

647

3034

Type 2 diabetes, wide definition

2349

9506

1.61

91.79

2.2

2.0

38.41

39.99

u/l

2.75

2012

8509

Asthma and allergy, excluding more controls

381

1218

3.20

91.77

2.0

1.2

38.17

39.59

u/l

0.78

355

1114

Nonalcoholic fatty liver disease

425

1491

3.06

91.14

2.1

2.0

43.87

39.49

u/l

3.89

384

1338

Disorders of lipoprotein metabolism and other lipidaemias

2405

9469

1.60

91.10

2.0

37.69

39.98

u/l

5.77

2069

8450

Diabetes, varying definitions

3069

12056

1.52

90.50

2.2

2.0

38.99

39.85

u/l

1.29

2642

10951

Intracranial trauma

1557

6256

1.78

90.44

1.9

2.0

40.77

40.07

u/l

0.59

1374

5633

Diabetes mellitus

3080

12079

1.51

90.19

2.2

2.0

39.04

39.82

u/l

1.13

2654

10971

Arthropathies in other diseases classified elsewhere

208

465

5.05

88.65

3.6

2.0

43.05

38.02

u/l

2.47

183

411

Abnormal results of function studies

341

1071

3.40

88.11

2.0

1.7

41.59

38.99

u/l

1.38

303

954

Care involving use of rehabilitation procedures

1875

10592

1.66

87.76

2.0

1.9

39.26

39.64

u/l

0.33

1670

9466

Other acute lower respiratory infections

1555

8683

1.74

87.70

2.0

1.9

38.38

39.19

u/l

0.84

1361

7706

Sciatica+with lumbago

1532

8227

1.75

87.27

1.9

2.0

39.60

39.40

u/l

0.14

1392

7340

Nutritional anaemias

1429

7909

1.78

87.00

1.9

38.37

39.04

u/l

0.54

1222

6934

Type 2 diabetes

2956

11583

1.51

86.76

2.2

2.0

38.84

39.80

u/l

1.49

2533

10497

Concussion

1351

6174

1.82

86.56

1.9

2.0

40.70

40.05

u/l

0.51

1199

5564

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

231

569

4.49

86.47

2.1

1.8

38.45

38.74

u/l

0.06

194

473

Asthma and allergy

381

1263

3.09

86.23

2.0

1.2

38.17

39.34

u/l

0.60

355

1142

Complications of medical and surgical care

2176

12799

1.59

86.04

2.0

38.94

39.34

u/l

0.40

1917

11394

Iron deficiency anaemia

1246

6808

1.85

85.84

1.9

38.79

39.16

u/l

0.23

1073

5979

Nephropathy related operations

460

1739

2.81

85.21

1.7

1.9

39.28

39.14

u/l

0.04

415

1519

Chronic rhinitis, nasopharyngitis and pharyngitis

1015

5296

1.98

85.12

2.1

2.0

38.93

39.60

u/l

0.52

915

4730

STROKE

1603

6391

1.74

85.04

1.8

2.0

37.91

40.65

u/l

5.42

1362

5827

Other/unspecified dorsalgia

1127

6057

1.89

83.57

2.0

39.52

39.27

u/l

0.16

1011

5402

Gout, unspecified

639

2833

2.35

83.15

2.0

1.7

37.80

38.33

u/l

0.23

536

2421

Disorders of the thyroid gland

2763

12071

1.51

82.68

2.0

1.9

39.27

39.10

u/l

0.16

2493

10714

Obesity and other hyperalimentation

1913

11577

1.63

82.57

2.1

2.0

38.74

39.46

u/l

0.82

1696

10424

Non-Hodgkin lymphoma, all, including Hilmo

467

1804

2.73

82.56

1.8

41.94

38.17

u/l

2.87

419

1526

Bleeding

2364

10963

1.56

82.34

1.9

2.0

39.23

39.30

u/l

0.06

2058

9687

Rheumatoid arthritis, including avohilmo

1168

6449

1.86

82.17

1.6

2.0

38.26

39.40

u/l

1.13

1036

5653

Acute bronchitis

1194

6494

1.85

81.98

2.0

1.9

38.89

39.10

u/l

0.13

1033

5728

Left bundle-branch block

279

810

3.68

81.65

2.2

1.6

34.31

39.36

u/l

3.21

214

719

Presence of other functional implants

1613

6653

1.72

81.64

1.9

1.8

38.55

39.27

u/l

0.65

1411

5802

Erysipelas

1560

8229

1.71

81.58

2.0

1.9

38.60

39.43

u/l

0.76

1340

7228

Obesity

1900

11539

1.62

81.31

2.1

2.0

38.75

39.48

u/l

0.84

1685

10389

Intestinal infectious diseases

3361

13367

1.46

81.09

2.0

39.73

39.33

u/l

0.49

2977

11969

ILD-related respiratory insufficiency

173

359

5.46

80.68

1.6

2.0

39.19

37.81

u/l

0.31

156

308

Eosinophilia

127

200

7.80

80.59

1.6

2.2

42.61

39.00

u/l

0.80

118

181

Acute upper respiratory infections of multiple and unspecified sites

2202

10546

1.57

80.31

2.0

39.31

39.67

u/l

0.35

2012

9435

Polyarthrosis

624

2565

2.34

80.04

1.8

1.9

39.49

39.38

u/l

0.05

533

2222

Shoulder lesions

2183

8467

1.59

79.91

1.9

2.0

40.07

39.32

u/l

0.89

1938

7516

Other antidepressants

3026

10564

1.49

79.77

1.9

2.0

39.56

39.39

u/l

0.16

2693

9432

Other demyelinating diseases of the central nervous system

219

554

4.45

79.68

1.4

2.2

34.70

40.75

u/l

5.43

209

509

Other and unspecified iron deficiency

994

5264

1.94

79.50

2.0

1.9

38.81

39.01

u/l

0.10

860

4629

Migraine with aura

775

3767

2.12

79.42

2.0

1.9

38.12

39.60

u/l

1.38

719

3454

Dental caries

803

3794

2.10

79.37

1.9

2.0

38.92

38.88

u/l

0.02

699

3345

Iridocyclitis in diseases classified elsewhere

134

226

7.05

79.01

4.6

2.2

42.25

39.87

u/l

0.51

123

203

Gout, strict definition

567

2449

2.42

78.55

1.8

1.7

36.81

38.23

u/l

0.78

470

2092

Exclusions for E4_PCOS_BROAD

597

2636

2.37

78.48

2.1

1.9

38.96

39.44

u/l

0.22

548

2375

Acute tubulo-interstitial nephritis

1710

9114

1.65

77.50

1.9

1.8

38.91

39.00

u/l

0.06

1487

8081

Any operation in hilmo

114

12.76

76.83

2.2

1.2

37.96

38.47

u/l

0.06

103

Other pleural conditions

352

1221

3.05

76.43

1.6

1.7

35.43

38.55

u/l

1.87

298

1030

Immunodeficiencies

237

655

4.00

75.71

2.8

1.9

40.51

39.15

u/l

0.44

224

583

Complications of procedures, not elsewhere classified

2348

12954

1.53

75.62

2.0

39.30

39.34

u/l

0.03

2079

11536

Caries of dentine

723

3390

2.15

75.61

1.9

2.0

38.65

38.83

u/l

0.08

631

2993

Osteoporosis

775

3575

2.10

75.57

2.4

1.8

39.88

39.28

u/l

0.31

654

3070

Obesity due to excess calories

1438

8625

1.71

75.39

2.1

2.0

38.61

39.44

u/l

0.82

1279

7781

Diplopia

465

1877

2.61

75.12

1.8

1.9

38.00

38.86

u/l

0.44

427

1662

Fibrosis and cirrhosis of liver

311

1024

3.27

74.68

2.1

1.8

47.82

38.60

u/l

6.58

278

896

Disorders of lens

1927

7623

1.61

74.41

2.1

2.0

39.30

39.54

u/l

0.18

1709

6694

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1519

9002

1.67

73.98

1.9

2.0

39.07

39.59

u/l

0.46

1372

8015

Respiratory insufficiency

228

615

3.87

73.42

1.7

1.2

35.26

38.13

u/l

1.27

193

503

Other general symptoms and signs

206

518

4.23

73.09

1.8

1.9

37.98

39.49

u/l

0.46

194

470

Other disorders involving the immune mechanism, not elsewhere classified

168

370

5.12

72.97

2.1

1.2

36.23

37.32

u/l

0.25

152

325

Diarrhoea and gastroenteritis of presumed infectious origin

2923

13411

1.46

72.67

2.0

39.80

39.40

u/l

0.48

2600

12005

Neoplasms

2231

7723

1.55

72.47

1.9

2.0

38.79

39.55

u/l

0.96

2043

7009

Hypertensive heart and/or renal disease

723

2590

2.14

72.33

1.6

1.8

37.22

40.12

u/l

2.85

589

2275

Other disorders of white blood cells

252

747

3.69

72.25

2.1

1.9

41.88

38.59

u/l

1.22

227

661

Nausea and vomiting

773

3805

2.05

71.91

1.9

1.8

39.18

39.15

u/l

0.02

679

3331

Immunodeficiency with predominantly antibody defects

150

305

5.61

71.80

2.6

1.2

40.93

38.29

u/l

0.78

138

272

Pulmonary heart disease, diseases of pulmonary circulation

919

4910

1.93

71.74

1.9

1.8

37.83

38.97

u/l

0.85

810

4241

Hypothyroidism, other/unspecified

2538

11340

1.49

71.63

2.0

1.9

39.59

39.13

u/l

0.52

2296

10089

Spondylosis

1518

7562

1.67

71.40

1.8

2.0

39.54

39.18

u/l

0.29

1353

6644

Pure hypercholesterolaemia

2041

8668

1.56

70.73

1.9

2.0

37.54

39.93

u/l

5.36

1742

7697

Disorders of conjunctiva

2401

13074

1.50

70.70

2.1

2.0

39.29

39.57

u/l

0.30

2180

11721

Abnormal findings on diagnostic imaging of other body structures

439

1773

2.59

70.64

2.5

1.7

39.98

39.47

u/l

0.18

398

1546

Other respiratory disorders and diseases

609

2831

2.23

70.42

1.8

36.00

38.58

u/l

2.45

539

2427

Other diseases of the respiratory system

609

2831

2.23

70.42

1.8

36.00

38.58

u/l

2.45

539

2427

Transplanted organ and tissue status

358

1313

2.89

70.32

1.8

40.13

39.37

u/l

0.24

326

1168

Intestinal infectious diseases

2700

14211

1.46

70.05

2.0

39.00

39.43

u/l

0.49

2367

12745

Diarrhoea and gastroenteritis of presumed infectious origin

2033

12078

1.54

69.74

2.1

2.0

39.04

39.45

u/l

0.39

1781

10839

Arthrosis

1954

6871

1.59

69.73

2.0

39.19

39.48

u/l

0.24

1747

6132

Mood disorders, excluding more controls

2768

11441

1.47

69.58

1.9

2.0

39.84

39.39

u/l

0.53

2478

10245

Lumbar disc prolapse

1819

8937

1.59

69.58

2.1

2.0

39.83

39.32

u/l

0.49

1631

7971

Other disorders of optic [2nd] nerve and visual pathways

267

838

3.44

69.56

2.4

2.0

39.05

39.19

u/l

0.04

244

749

Follow-up examination after treatment for conditions other than malignant neoplasms

1144

4259

1.81

69.49

2.0

1.9

40.57

39.15

u/l

1.40

1021

3768

Depression

2788

13183

1.45

68.85

1.9

2.0

39.74

39.52

u/l

0.23

2506

11825

Type 2 diabetes, definitions combined, including avohilmo

2763

11158

1.46

68.59

2.2

2.0

38.27

39.84

u/l

3.23

2363

10098

Diverticular disease of intestine

2026

8456

1.56

68.52

2.0

37.94

39.39

u/l

2.40

1743

7431

Migraine without aura

627

2983

2.17

68.16

2.2

2.0

39.21

39.98

u/l

0.46

585

2784

Anxiety disorders, excluding more controls

2441

10817

1.49

67.96

2.0

2.1

39.76

39.57

u/l

0.17

2205

9727

Irritable bowel syndrome

853

4532

1.94

67.88

1.8

2.0

39.97

39.23

u/l

0.53

772

4048

Depression or dysthymia

2009

7203

1.56

67.77

1.9

2.1

40.30

39.37

u/l

1.11

1784

6419

Type 2 diabetes, definitions combined

2738

11159

1.46

67.72

2.2

2.0

38.30

39.85

u/l

3.12

2331

10093

Other neurological diseases

2007

10400

1.54

67.71

1.8

1.9

38.39

39.11

u/l

0.87

1762

9115

Giant cell arteritis

191

491

4.30

67.61

1.6

1.9

33.38

39.57

u/l

4.42

171

426

Other disorders of fluid, electrolyte and acid-base balance

860

4354

1.93

67.57

1.8

39.46

39.50

u/l

0.02

740

3801

Papilloedema, unspecified

137

272

5.78

67.49

2.9

2.1

39.14

38.83

u/l

0.06

124

248

Mood [affective] disorders

2956

13547

1.43

67.26

1.9

2.0

39.85

39.48

u/l

0.42

2653

12134

Dysphagia

721

3631

2.05

67.16

1.8

1.9

39.37

39.03

u/l

0.16

628

3139

Pericarditis

164

377

4.77

67.00

2.0

1.6

34.68

40.51

u/l

2.57

148

340

Mood disorders

2960

13557

1.43

66.95

1.9

2.0

39.83

39.49

u/l

0.40

2658

12142

Type 2 diabetes, strict (exclude DM1)

2740

11236

1.45

65.62

2.2

2.0

38.31

39.84

u/l

3.03

2333

10164

Extracorporeal dialysis

258

825

3.39

65.39

1.5

1.9

38.53

38.32

u/l

0.05

237

725

Diseases of salivary glands

984

5543

1.83

64.98

2.0

39.14

39.12

u/l

0.01

885

4938

Hypothyreosis and Thyroxine purchase for inclusion criteria

2604

11890

1.46

64.85

2.0

1.9

39.60

39.15

u/l

0.53

2360

10579

Other CVD (FINNGEN)

343

960

2.89

64.74

2.0

1.7

38.32

41.17

u/l

1.52

286

883

Benign neoplasms

2791

10780

1.45

64.68

1.9

2.0

38.83

39.36

u/l

0.68

2504

9719

Other cataract

1232

5535

1.72

64.13

2.1

1.9

39.53

39.14

u/l

0.26

1072

4821

Later onset COPD, excluding more controls

444

1412

2.50

64.06

1.4

1.2

36.81

37.22

u/l

0.14

376

1139

Disorders of synovium and tendon

1480

8140

1.62

63.04

1.9

2.0

40.15

39.43

u/l

0.69

1343

7261

Coagulation defects, purpura and other haemorrhagic conditions

619

3026

2.12

63.02

2.1

1.9

41.79

38.83

u/l

2.19

558

2679

Other disorders of eye and adnexa

486

2166

2.35

62.82

2.3

1.9

37.56

39.38

u/l

1.34

451

1948

Neurotic, stress-related and somatoform disorders

2575

12621

1.45

62.66

2.0

39.69

39.72

u/l

0.03

2336

11363

Rheumatism, unspecified

459

2007

2.39

62.00

2.0

38.86

39.48

u/l

0.29

406

1790

Other arthrosis

1405

6002

1.65

61.88

2.0

39.93

39.53

u/l

0.29

1258

5318

SLE (Finngen)

158

376

4.61

61.84

1.6

2.1

39.40

40.20

u/l

0.18

141

335

Postprocedural disorders of nervous system

294

1042

3.01

61.84

2.2

2.0

39.19

39.89

u/l

0.26

279

963

Hernia of abdominal wall, postoperative

490

2196

2.30

61.77

2.1

1.9

39.54

38.97

u/l

0.23

421

1917

Seropositive rheumatoid arthritis

685

3475

2.02

61.70

1.6

2.0

37.49

39.80

u/l

2.14

599

3047

Genitourinary diseases

1642

5193

1.61

61.39

2.0

38.80

39.78

u/l

1.00

1483

4674

Anxiety disorders

2591

12711

1.44

61.34

2.0

39.77

39.67

u/l

0.09

2348

11432

Persons encountering health services in other circumstances

1135

6717

1.72

61.24

1.8

1.9

40.05

39.22

u/l

0.66

1024

6000

Viral infections characterized by skin and mucous membrane lesions

2421

14486

1.45

61.08

2.1

1.9

39.41

39.36

u/l

0.04

2178

12945

Gonarthrosis [arthrosis of knee](FG)

1947

7498

1.53

60.68

2.0

2.1

38.91

40.07

u/l

1.56

1715

6652

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

148

342

4.84

60.53

1.8

1.2

35.88

36.75

u/l

0.17

134

302

Reactive arthropathies, FINNGEN

262

881

3.16

60.39

1.9

2.0

37.32

39.41

u/l

0.95

242

797

All influenza

707

3667

1.98

60.39

2.2

1.9

39.21

39.59

u/l

0.18

619

3236

Other disorders of urethra and urinary system

1949

9424

1.52

60.09

1.9

39.90

39.27

u/l

0.67

1726

8375

Other pulmonary heart/vessel disease

190

527

3.91

60.07

1.9

2.0

36.80

38.91

u/l

0.61

168

459

Secondary right heart disease

180

483

4.07

59.83

1.8

2.0

36.87

38.77

u/l

0.50

158

421

Other retinal disorders

1689

8585

1.56

59.83

1.9

40.18

38.74

u/l

1.86

1461

7506

Symptoms and signs involving the urinary system

2087

10846

1.49

59.38

1.7

2.0

38.26

39.37

u/l

1.55

1830

9564

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1704

11104

1.54

59.28

2.0

1.9

38.99

39.27

u/l

0.22

1496

9836

Episcleritis

226

708

3.45

59.21

1.6

2.1

37.02

39.08

u/l

0.87

210

645

Recurrent or chronic depression

1221

5202

1.68

57.99

2.0

2.2

40.06

39.88

u/l

0.11

1103

4727

Lung cancer and mesothelioma

409

1470

2.44

57.95

1.7

1.2

37.09

37.74

u/l

0.25

350

1200

Chronic gastritis

749

4026

1.91

57.51

1.7

1.9

39.04

38.93

u/l

0.05

635

3453

Urticaria

891

5061

1.81

57.16

2.1

2.0

41.38

39.40

u/l

2.18

802

4574

Functional dyspepsia

789

4322

1.88

57.16

1.9

2.0

41.09

39.15

u/l

1.86

712

3843

Benign neoplasm of colon, rectum, anus and anal canal

1697

9768

1.54

56.91

2.0

1.9

39.58

39.09

u/l

0.44

1463

8502

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2638

11328

1.42

56.77

2.1

2.0

39.03

39.96

u/l

1.29

2280

10258

Keratitis

998

5861

1.74

56.75

2.1

2.0

40.31

39.20

u/l

0.92

907

5188

Spondylopathies (FG)

435

1932

2.34

56.48

1.9

2.0

38.40

39.44

u/l

0.56

396

1749

Coxibs

759

2075

1.97

56.17

1.7

1.9

37.56

38.19

u/l

0.35

680

1804

Implicit fungal Sepsis

249

851

3.12

55.96

2.1

1.9

39.79

39.53

u/l

0.06

221

748

Spinal stenosis

1321

6279

1.63

55.82

1.9

39.65

38.89

u/l

0.61

1160

5430

Noninfective enteritis and colitis

1307

8241

1.62

55.74

1.8

2.0

39.29

39.45

u/l

0.10

1147

7375

Disorders of gallbladder, biliary tract and pancreas

2745

12508

1.40

54.98

1.9

2.0

39.21

39.32

u/l

0.10

2440

11133

Spondyloarthritis

534

2604

2.12

54.54

1.9

2.0

38.33

39.35

u/l

0.59

475

2317

Other degenerative diseases of the nervous system

716

2830

1.93

54.48

1.5

1.8

37.14

39.07

u/l

1.78

640

2473

Pulmonary embolism

807

4517

1.83

54.38

1.9

38.16

39.04

u/l

0.55

714

3907

Hyperlipidaemia, other/unspecified

1014

5549

1.72

54.35

1.9

1.8

37.17

39.24

u/l

2.34

842

4840

Hypertensive Heart Disease

610

2409

2.04

54.10

1.6

1.8

37.19

40.02

u/l

2.36

488

2112

Purpura and other haemorrhagic conditions

432

1954

2.31

53.93

2.1

1.9

42.11

38.83

u/l

1.81

394

1721

Bronchiectasis

265

957

2.93

53.72

2.0

1.8

38.79

39.11

u/l

0.09

236

815

Conjunctivitis

2103

12268

1.45

53.62

2.1

2.0

39.33

39.74

u/l

0.44

1914

11026

Optic neuritis

197

605

3.55

53.55

1.9

2.1

38.49

39.95

u/l

0.51

192

556

Other disorders of adrenal gland

192

579

3.59

53.55

2.5

1.9

37.72

38.87

u/l

0.29

174

518

Adrenocortical insufficiency

170

476

3.93

53.38

2.6

1.9

37.74

39.41

u/l

0.42

156

428

Other disorders of skin and subcutaneous tissue, not elsewhere classified

446

2052

2.26

53.29

2.1

1.8

40.21

38.63

u/l

0.84

387

1797

Pulmonary heart disease

807

4545

1.82

53.27

1.9

1.8

38.16

38.95

u/l

0.47

714

3928

Other functional intestinal disorders

1200

6948

1.63

53.04

1.8

1.9

39.27

39.15

u/l

0.07

1074

6119

Ocular pain

306

1200

2.70

52.87

2.5

2.0

36.75

39.62

u/l

1.87

286

1090

Senile cataract

1647

6673

1.54

52.64

2.1

1.9

39.29

39.27

u/l

0.01

1452

5815

Infections of the skin and subcutaneous tissue

1614

10703

1.52

52.54

2.0

39.40

39.29

u/l

0.07

1426

9608

Diseases of the ear and mastoid process

3284

12263

1.36

52.44

2.0

39.07

39.48

u/l

0.53

2947

10996

Insulin medication

1619

9082

1.52

52.44

2.1

1.9

40.39

39.49

u/l

0.80

1388

8069

Chronic laryngitis and laryngotracheitis

444

2056

2.25

52.25

1.9

41.65

39.24

u/l

1.62

397

1796

Glomerulonephritis

339

1403

2.54

52.15

1.6

1.9

37.53

39.15

u/l

0.65

294

1243

Hypopituitarism

266

979

2.88

52.14

2.1

2.0

40.10

39.95

u/l

0.04

247

884

Ischaemic heart disease, wide definition

2083

8973

1.46

51.90

1.9

2.0

37.65

39.96

u/l

4.94

1738

7966

Reactive arthropathies

302

1185

2.68

51.89

1.8

2.0

37.35

38.87

u/l

0.66

277

1062

Abnormalities of gait and mobility

370

1596

2.42

51.72

1.6

1.8

38.50

38.57

u/l

0.02

315

1354

Temporal arteritis

157

425

4.05

51.71

1.5

1.9

33.63

39.08

u/l

3.01

141

365

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

456

2146

2.21

51.60

1.8

47.94

38.46

u/l

9.91

408

1876

Bacterial pneumoniae

1054

5645

1.68

51.53

2.1

1.9

37.22

39.28

u/l

2.65

914

4939

Secondary and unspecified malignant neoplasm of lymph nodes

283

1082

2.76

51.39

1.8

1.9

43.85

38.55

u/l

3.33

257

924

L04AD Calcineurin inhibitors

373

1622

2.42

51.38

2.1

1.9

40.58

38.83

u/l

0.75

342

1451

Other inflammation of eyelid

429

1975

2.26

51.28

2.0

1.9

39.10

39.65

u/l

0.22

380

1750

Rotator cuff syndrome

1628

7799

1.52

51.10

1.9

2.0

39.82

39.23

u/l

0.53

1449

6882

Viral infections characterized by skin and mucous membrane lesions

1157

7260

1.63

50.60

2.2

2.0

38.83

39.41

u/l

0.43

1034

6454

Viral pneumonia

386

1710

2.34

50.49

2.2

1.8

36.20

38.86

u/l

1.68

342

1508

Migraine with aura and triptan purchases

491

2400

2.12

50.05

2.1

2.0

38.47

39.35

u/l

0.49

462

2234

Mycoses

768

4350

1.81

49.94

2.2

1.9

39.66

38.87

u/l

0.47

685

3832

Preparatory care for dialysis

189

593

3.48

49.72

1.8

2.0

41.02

38.88

u/l

0.65

168

520

Insulin, combination of fast acting with intermediate-acting or long-acting

1620

10009

1.50

49.69

2.1

1.9

40.39

38.98

u/l

1.58

1388

8824

Other skin changes

531

2681

2.05

49.51

2.4

1.9

39.68

38.93

u/l

0.35

477

2331

Benign neoplasm: Colon

1409

8865

1.55

49.41

2.0

1.9

39.62

38.84

u/l

0.71

1207

7678

Bacterial pneumonia (organism specified)

1150

6550

1.62

49.39

2.1

1.8

37.62

39.01

u/l

1.44

1004

5717

Biological medication for rheuma

549

2809

2.02

49.37

1.6

2.0

36.97

39.56

u/l

2.59

514

2558

Diabetes medication

2885

12664

1.37

49.22

2.1

2.0

39.19

39.70

u/l

0.58

2505

11421

Budesonide

384

1715

2.31

49.12

2.0

1.5

40.10

39.54

u/l

0.24

344

1516

Bacterial pneumonia, not elsewhere classified

990

5287

1.68

48.77

2.1

1.9

37.21

39.16

u/l

2.36

857

4625

DVT of lower extremities and pulmonary embolism

1095

6817

1.63

48.77

2.0

1.9

38.22

38.76

u/l

0.36

964

5907

Vasomotor and allergic rhinitis

1040

6306

1.65

48.46

2.0

38.74

39.76

u/l

0.99

936

5706

Disorders of skin appendages

1336

8745

1.55

48.41

2.0

40.41

39.33

u/l

1.13

1215

7879

Cirrhosis of liver, NAS

213

730

3.14

48.03

2.1

1.9

48.70

38.32

u/l

5.19

188

631

Diseases of the digestive system

1180

7508

1.59

47.65

1.8

1.9

40.56

38.76

u/l

2.01

1034

6558

Giant cell arteritis with polymyalgia rheumatica

157

450

3.82

47.60

1.5

1.9

33.63

39.17

u/l

3.05

141

388

5-aminosalicylic acid

540

2774

2.00

47.52

1.8

1.5

38.46

39.73

u/l

0.79

467

2469

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1550

10502

1.50

47.49

2.0

1.9

39.00

39.21

u/l

0.15

1359

9287

Other (seronegative) rheumatoid arthritis, wide

560

2929

1.98

47.19

1.6

1.9

38.32

39.30

u/l

0.55

503

2575

Diabetes, insulin treatment (Kela reimbursement)

2763

12363

1.37

47.17

2.1

2.0

38.97

39.77

u/l

1.07

2390

11096

Cervical disc disorders

976

5985

1.66

47.12

1.9

2.0

39.59

39.13

u/l

0.30

871

5264

Cervicalgia

588

3123

1.94

47.06

1.8

2.0

41.13

39.05

u/l

1.66

513

2770

Wegener granulomatosis

189

5.83

46.97

1.6

2.2

30.94

39.73

u/l

4.41

170

Somatoform disorder

508

2574

2.04

46.97

2.0

39.78

39.58

u/l

0.08

454

2327

Venous thromboembolism

1411

9087

1.53

46.84

2.0

1.9

38.13

39.05

u/l

0.84

1251

7899

Gonarthrosis

1632

6270

1.50

46.65

2.0

38.99

39.48

u/l

0.41

1449

5558

Other gastritis (incl. Duodenitis)

622

3376

1.89

46.53

2.0

1.8

41.06

39.06

u/l

1.32

554

2932

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

961

5897

1.67

46.47

2.0

38.41

39.43

u/l

0.83

867

5253

Abnormal serum enzyme levels

783

4432

1.76

46.37

1.8

42.45

37.75

u/l

6.26

691

3846

Other viral diseases

1046

6497

1.63

46.37

1.8

2.0

39.48

39.37

u/l

0.06

975

5917

Localized swelling, mass and lump of skin and subcutaneous tissue

866

5175

1.71

46.35

2.1

1.9

40.26

38.95

u/l

1.07

778

4558

Oxycodone

987

5491

1.66

46.27

1.7

1.9

38.42

38.98

u/l

0.35

862

4798

Constipation

2371

11947

1.39

46.27

1.8

2.0

39.06

39.36

u/l

0.29

2088

10594

Abnormal weight loss

303

1262

2.52

46.06

1.6

1.8

38.79

38.86

u/l

0.02

262

1094

Other anxiety disorders

1297

7370

1.55

45.87

1.8

2.0

39.27

39.62

u/l

0.25

1177

6749

Other bacterial intestinal infections

643

3547

1.86

45.66

1.8

1.9

38.74

38.87

u/l

0.05

545

3135

Seronegative rheumatoid arthritis

337

1473

2.38

45.56

1.6

2.1

36.71

40.16

u/l

2.62

303

1301

Osteoporosis with pathological fracture (FG)

210

733

3.01

45.25

2.7

2.0

40.43

40.48

u/l

0.01

169

630

Hypothyroidism, strict autoimmune, 3 medication purchases required

2261

11073

1.40

45.02

2.0

1.9

39.81

39.23

u/l

0.69

2041

9848

Coronary atherosclerosis

1618

6977

1.49

45.00

1.8

1.9

37.76

39.92

u/l

3.43

1336

6223

Other bacterial intestinal infections

515

2659

2.00

44.98

1.7

1.9

38.63

39.01

u/l

0.15

434

2339

Systemic lupus erythematosus

158

475

3.62

44.51

1.6

2.0

39.40

39.60

u/l

0.04

141

425

Disorders of ocular muscles, binocular movement, accommodation and refraction

1279

8386

1.54

44.36

2.0

38.95

39.41

u/l

0.36

1165

7552

Exposure to unspecified factor

2705

14579

1.35

44.19

1.9

2.0

39.93

39.30

u/l

0.83

2371

13088

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1436

7748

1.51

44.16

2.1

1.9

37.17

39.68

u/l

4.23

1206

6771

COPD

1079

5612

1.60

43.31

1.8

37.71

38.56

u/l

0.63

924

4802

Non-follicular lymphoma

302

1293

2.45

43.18

1.9

1.8

42.63

38.38

u/l

2.38

268

1109

Use of hypnotics and sedatives

2928

12718

1.34

42.99

2.0

39.00

39.39

u/l

0.46

2592

11386

Other diseases of urinary system

2686

11274

1.35

42.89

1.9

2.0

38.76

39.27

u/l

0.63

2391

10053

Secondary uncertain malignant neoplasm

367

1707

2.23

42.71

1.7

1.8

41.58

38.35

u/l

1.93

324

1442

Ulcer of lower limb, not elsewhere classified

403

1944

2.15

42.70

2.1

1.8

41.34

37.88

u/l

2.32

332

1668

Insulin, intermediate and long-acting

1412

9326

1.49

42.68

2.0

1.9

40.84

38.84

u/l

2.55

1204

8216

Polyarthritis, unspecified

149

443

3.63

42.53

1.9

2.0

37.57

38.79

u/l

0.32

130

391

Bacterial intestinal infections, IBD co-morbidities

512

2697

1.96

42.17

1.7

1.9

38.61

39.03

u/l

0.18

430

2369

Fungal Sepsis

159

499

3.43

41.64

2.0

41.13

39.59

u/l

0.32

146

439

Zoster [herpes zoster]

1278

8434

1.52

41.54

2.1

1.9

38.43

39.29

u/l

0.82

1137

7373

Diseases of arteries, arterioles and capillaries

1671

8641

1.45

41.51

1.8

1.9

38.02

39.09

u/l

1.17

1419

7519

Other and unspecified visual disturbances

327

1473

2.32

41.47

1.8

1.9

39.31

38.87

u/l

0.14

282

1310

Other noninfective gastroenteritis and colitis

672

3862

1.78

41.43

1.9

40.00

39.05

u/l

0.52

585

3426

Weight loss

313

1388

2.36

41.22

1.6

1.8

38.75

38.86

u/l

0.02

271

1210

Other medical care

1127

6614

1.56

41.00

1.5

1.8

37.65

39.11

u/l

1.39

993

5786

Candidiasis

791

4773

1.70

40.92

2.1

1.9

40.22

38.75

u/l

1.17

695

4257

Hypokalaemia

342

1574

2.25

40.90

1.9

1.8

39.05

39.54

u/l

0.16

296

1383

Internal derangement of knee

934

5842

1.62

40.64

2.0

39.76

39.37

u/l

0.23

833

5208

Cerebral cysts

206

757

2.88

40.61

1.7

2.0

39.29

39.32

u/l

0.01

186

689

Diaphragmatic hernia

956

6059

1.61

40.47

1.9

39.62

39.09

u/l

0.31

815

5300

Insulin, fast-acting

951

6021

1.61

40.24

2.3

1.9

42.02

39.02

u/l

3.54

828

5348

Tumor necrosis factor alpha inhibitors

481

2527

1.97

40.14

1.6

2.0

36.96

39.43

u/l

2.22

451

2304

Symptoms and signs involving speech and voice

893

5582

1.63

40.11

1.9

38.66

39.11

u/l

0.26

779

4928

Other viral diseases

798

4835

1.68

40.04

1.8

2.0

39.37

39.39

u/l

0.01

742

4404

All anxiety disorders

1714

9611

1.43

39.92

1.9

2.1

39.70

39.66

u/l

0.03

1562

8737

Implicit fungal Sepsis

150

467

3.47

39.87

2.0

41.35

39.62

u/l

0.35

137

410

SLE, ICD10

154

493

3.40

39.32

1.6

2.0

39.63

39.86

u/l

0.05

137

439

SLE, strict definition

154

493

3.40

39.32

1.6

2.0

39.63

39.86

u/l

0.05

137

439

Anxiety (asthma-related co-morbidities)

1680

9217

1.43

39.13

1.9

2.1

39.66

39.71

u/l

0.03

1528

8404

Other reaction to severe stress, and adjustment disorders

1015

6569

1.57

39.11

2.1

38.91

39.71

u/l

0.60

918

5992

Conjunctivitis (acute, non atopic)

764

4605

1.69

39.09

2.0

1.9

39.19

39.72

u/l

0.32

701

4136

Drug-induced adrenocortical insufficiency

101

246

4.66

39.02

3.2

2.2

34.72

39.37

u/l

1.54

220

Non-Hodgkin lymphoma, all

147

457

3.42

38.92

1.5

1.8

40.02

38.54

u/l

0.30

133

373

Other/unspecified reactive arthropathies

239

968

2.61

38.85

1.9

2.0

37.16

39.28

u/l

0.96

224

870

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2572

12450

1.34

38.84

2.1

2.0

39.50

39.30

u/l

0.19

2264

11112

Carpal tunnel syndrome

1607

10020

1.43

38.79

2.0

40.10

39.46

u/l

0.62

1432

8896

Temporomandibular joint disorders, including avohilmo

1205

7985

1.51

38.77

1.9

2.0

39.25

39.44

u/l

0.12

1119

7265

Other (not insulin) diabetes medications

2634

11834

1.33

38.76

2.1

2.0

38.36

39.67

u/l

2.35

2274

10634

Diseases of the myoneural junction and muscle

354

1691

2.17

38.63

1.7

1.8

39.65

38.86

u/l

0.28

316

1478

Acetic acid derivatives and related substances

692

2046

1.78

38.47

1.8

2.0

37.79

38.19

u/l

0.19

602

1776

Chronic apical periodontitis

3042

13400

1.31

38.04

1.9

2.0

39.48

39.41

u/l

0.05

2698

12017

Benzodiazepine use

2703

14231

1.32

37.98

1.8

2.0

39.32

39.36

u/l

0.03

2369

12754

ILD medications: pirfenidone

7.60

37.40

1.3

1.7

35.32

40.96

u/l

0.82

Other symptoms and signs involving the circulatory and respiratory systems

199

747

2.78

37.40

1.9

1.8

37.63

39.57

u/l

0.69

179

660

Enterocolitis due to Clostridium difficile

302

1372

2.28

37.36

1.8

37.52

38.51

u/l

0.34

251

1186

Encephalitis

135

412

3.58

37.29

1.9

2.1

32.55

39.20

u/l

3.95

124

370

Cystitis

2230

9858

1.36

37.17

1.9

38.62

39.20

u/l

0.69

2003

8781

Meniscus derangement

1363

6305

1.48

36.95

1.9

2.0

39.68

39.53

u/l

0.09

1222

5597

Enthesopathies of lower limb, excluding foot

615

3568

1.77

36.88

2.1

2.0

40.22

39.26

u/l

0.56

560

3183

Special screening examination for infectious and parasitic diseases

621

2616

1.78

36.81

2.1

2.0

41.00

39.46

u/l

1.19

565

2399

Cholelithiasis, broad definition with cholecystitis

2282

11519

1.35

36.73

2.0

38.83

39.23

u/l

0.43

2020

10225

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

419

2169

1.99

36.55

1.7

1.9

42.10

38.57

u/l

2.46

376

1858

Thyroiditis, ILD-related definition

339

1628

2.16

36.48

2.1

2.0

39.52

39.87

u/l

0.12

316

1474

Benign intracranial hypertension

115

6.56

36.48

1.7

2.0

38.60

39.26

u/l

0.09

104

Amiodarone users

297

1363

2.27

36.08

3.3

1.7

36.12

38.62

u/l

1.21

240

1155

Inflammatory diseases of the central nervous system

276

1230

2.35

36.05

1.9

35.21

39.28

u/l

3.13

250

1097

Suggestive for eosinophilic asthma

281

1264

2.32

35.81

2.0

1.8

36.81

38.79

u/l

0.94

258

1101

Soft tissue disorders related to use, overuse and pressure

701

4248

1.69

35.68

2.0

39.40

39.16

u/l

0.11

618

3757

Pain in thoracic spine

430

2262

1.96

35.65

1.7

2.0

40.04

38.98

u/l

0.54

390

2032

Convulsions, not elsewhere classified

520

2857

1.83

35.62

1.7

1.8

40.59

38.97

u/l

0.89

471

2549

Selective serotonin reuptake inhibitors

2648

10569

1.32

35.50

1.9

2.0

39.32

39.39

u/l

0.05

2367

9436

Other disorders of kidney and ureter

374

1883

2.06

35.47

2.2

1.8

39.19

38.43

u/l

0.26

324

1641

Chronic diseases of tonsils and adenoids

2057

9642

1.36

35.30

2.1

2.0

39.13

39.83

u/l

0.83

1866

8671

Insulin, fast-acting or short human

951

6205

1.56

35.29

2.3

1.9

42.02

39.01

u/l

3.56

828

5500

393

2014

2.01

35.27

2.2

2.0

37.71

39.53

u/l

1.01

350

1833

Asthma mixed form (mode), excluding more controls

134

416

3.35

35.17

2.0

1.2

39.43

38.06

u/l

0.30

124

364

Any mental disorder

2981

11598

1.30

35.15

1.9

2.0

39.39

39.34

u/l

0.04

2644

10381

Disorders resulting from impaired renal tubular function

144

474

3.28

35.02

1.6

2.0

39.23

39.18

u/l

0.01

127

426

Degeneration of macula and posterior pole

1094

5823

1.52

34.92

1.9

1.8

39.79

38.45

u/l

1.22

943

4968

Vasculitis limited to skin, not elsewhere classified

112

316

3.87

34.86

1.7

2.0

38.23

38.74

u/l

0.09

281

Deforming dorsopathies

717

4397

1.66

34.79

2.0

1.9

39.18

39.34

u/l

0.08

650

3909

Migraine without aura and triptan purchases

470

2567

1.88

34.69

2.4

2.0

38.89

39.48

u/l

0.30

439

2391

Oxicams

580

1851

1.81

34.64

1.8

1.9

39.89

37.94

u/l

1.34

507

1592

Cholelithiasis

2185

11337

1.34

34.52

2.0

38.77

39.28

u/l

0.56

1937

10057

Other symptoms and signs involving cognitive functions and awareness

1120

6899

1.50

34.50

1.7

1.9

38.02

38.88

u/l

0.70

971

6007

Fall on same level

3085

13219

1.29

34.19

1.9

2.0

39.98

39.26

u/l

1.09

2723

11934

Adalimumab

309

1477

2.18

33.86

1.7

2.1

36.40

39.58

u/l

2.20

289

1356

Mycoses

2243

14852

1.33

33.81

2.0

38.98

39.47

u/l

0.55

1989

13308

Other encephalitis

125

387

3.52

33.79

1.9

2.1

32.71

38.56

u/l

3.08

116

349

Obesity, other/unspecified

925

6064

1.55

33.77

2.2

2.0

38.44

39.39

u/l

0.74

819

5500

Other enthesopathies

779

4916

1.62

33.64

2.1

39.46

39.42

u/l

0.02

694

4388

Disorders of muscles

298

1406

2.20

33.61

2.0

38.52

38.72

u/l

0.06

273

1261

Other and unspecified immunodeficiencies with predominantly antibody defects

139

5.67

33.60

2.9

1.2

42.30

37.19

u/l

1.04

125

Other symptoms and signs involving the digestive system and abdomen

444

2406

1.89

33.55

2.0

39.56

39.77

u/l

0.08

382

2126

Other disorders of ear

2393

11985

1.32

33.44

2.0

39.34

39.47

u/l

0.12

2124

10634

Excessive, frequent and irregular menstruation

1011

3625

1.55

33.41

1.9

2.0

39.81

39.74

u/l

0.04

911

3282

Diabetic nephropathy, excluding more controls

421

1833

1.95

33.40

1.9

2.0

40.97

37.28

u/l

2.37

351

1553

Retinal detachments and breaks

874

5681

1.57

33.18

1.9

1.8

39.76

38.65

u/l

0.83

760

4924

Other disorders of conjunctiva

391

2045

1.97

33.17

2.2

1.9

38.31

38.81

u/l

0.21

351

1785

Other diseases of hard tissues of teeth

1531

5618

1.43

33.16

1.9

39.34

38.96

u/l

0.30

1369

4937

Hypermobility syndrome

183

706

2.73

32.87

2.2

2.1

39.75

39.67

u/l

0.02

171

658

Other chronic obstructive pulmonary disease

989

5417

1.53

32.79

1.7

1.8

37.41

38.50

u/l

0.87

842

4630

Emphysema

204

829

2.56

32.68

1.6

1.8

38.86

37.90

u/l

0.22

180

698

Pruritus

309

1497

2.14

32.53

1.9

40.15

39.79

u/l

0.12

288

1344

Asthma mixed form (mode)

134

437

3.18

32.46

2.0

1.2

39.43

37.92

u/l

0.34

124

380

Respiratory disorders in diseases classified elsewhere

184

4.91

32.45

1.8

2.3

36.36

39.23

u/l

0.54

163

Drug-induced cataract

111

328

3.73

32.44

3.9

2.1

38.11

39.68

u/l

0.33

101

290

Other and unspecified vasculitis limited to skin

102

284

3.92

32.41

1.7

2.0

38.97

38.72

u/l

0.04

252

Protozoal diseases

123

387

3.46

32.37

2.2

2.0

41.71

38.87

u/l

0.59

111

345

Radiculopathy

423

2287

1.90

32.25

1.8

1.9

39.16

38.40

u/l

0.34

392

1994

Visual impairment including blindness (binocular or monocular)

200

812

2.57

32.16

1.8

40.07

38.61

u/l

0.43

171

704

Cerebrovascular diseases

1834

9572

1.36

31.89

1.7

2.0

37.67

39.42

u/l

2.90

1548

8387

Other and unspecified urticaria

536

3124

1.76

31.77

2.0

41.78

39.20

u/l

2.22

479

2824

Bell's palsy

337

1701

2.05

31.73

2.6

1.9

39.95

39.39

u/l

0.19

312

1507

Granulomatous disorders of skin and subcutaneous tissue

113

342

3.59

31.64

2.0

40.61

38.76

u/l

0.37

105

303

Coxarthrosis [arthrosis of hip](FG)

1220

5958

1.46

31.58

1.9

2.0

38.77

39.86

u/l

1.06

1069

5219

Glucagon-like peptide-1 (GLP-1) analogues

788

5071

1.59

31.48

2.4

2.0

38.34

40.07

u/l

1.46

690

4556

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

788

5071

1.59

31.48

2.4

2.0

38.34

40.07

u/l

1.46

690

4556

Other metabolic disorders

379

1997

1.96

31.43

1.9

2.0

39.28

39.83

u/l

0.20

339

1819

Asthma and opportunity respiratory infection

155

564

2.92

31.34

2.1

1.9

36.47

39.45

u/l

1.17

135

484

Pneumocystosis

228

4.30

31.21

2.0

2.1

43.27

38.13

u/l

0.94

201

Voice disturbances

704

4424

1.63

31.14

2.0

39.00

39.29

u/l

0.14

623

3912

Other abnormal immunological findings in serum

251

4.07

30.99

1.8

2.2

37.98

39.19

u/l

0.25

227

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

272

1281

2.21

30.98

2.0

1.9

38.15

39.14

u/l

0.34

236

1152

Statin medication

1860

7775

1.36

30.89

2.0

2.1

38.18

40.69

u/l

5.61

1643

7179

Angina pectoris

1325

6243

1.43

30.85

1.9

38.49

39.74

u/l

1.18

1119

5539

Migraine, single triptan purchase ok & required. ICD-code if available is included

2061

10592

1.33

30.80

2.1

39.58

39.76

u/l

0.15

1914

9575

Triptan medication for migraine, single purchase ok

2061

10592

1.33

30.80

2.1

39.58

39.76

u/l

0.15

1914

9575

Hypertensive Renal Disease

115

355

3.42

30.78

1.4

1.9

37.85

39.92

u/l

0.51

101

300

Abnormal involuntary movements

366

1921

1.96

30.74

1.6

1.9

38.75

39.11

u/l

0.12

333

1689

Pain and other conditions associated with female genital organs and menstrual cycle

538

2900

1.74

30.66

2.0

39.66

39.71

u/l

0.02

494

2650

Artrosis, including avohilmo

2216

9259

1.32

30.49

2.0

39.41

39.37

u/l

0.03

1977

8309

Myositis

107

320

3.62

30.47

1.6

2.0

37.01

37.74

u/l

0.13

282

Biguanides

2510

11914

1.30

30.33

2.1

2.0

38.12

39.86

u/l

3.64

2155

10694

Childhood asthma (age<16), excluding more controls

268

972

2.21

30.28

2.0

1.2

42.04

39.13

u/l

1.46

246

912

Injuries to the knee and lower leg

3133

13884

1.26

30.24

2.0

39.67

39.30

u/l

0.44

2785

12433

Ulcerative colitis, NAS

398

2158

1.90

30.24

1.8

2.0

38.42

39.41

u/l

0.46

335

1958

Hypertrophic cardiomyopathy

152

559

2.90

30.24

2.8

1.9

37.71

38.99

u/l

0.25

123

492

Other CVD

463

2627

1.80

30.07

1.9

1.7

37.19

38.61

u/l

0.73

389

2239

Other viral diseases, not elsewhere classified

689

4316

1.62

30.05

1.8

2.0

40.17

39.47

u/l

0.38

643

3926

Endocarditis

113

351

3.41

30.01

2.0

1.6

37.44

40.21

u/l

0.64

101

310

Allergic rhinitis

813

5260

1.56

29.91

2.0

38.75

39.77

u/l

0.86

733

4825

Polycystic ovarian syndrome, consortium definition

1830

8096

1.35

29.87

1.9

2.0

40.23

39.72

u/l

0.51

1631

7357

Non-selective monoamine reuptake inhibitors

963

6290

1.50

29.80

1.9

2.0

38.86

39.78

u/l

0.75

853

5547

Cervicobrachial syndrome

581

3520

1.69

29.75

2.1

2.0

39.45

39.35

u/l

0.04

532

3142

Zoster [herpes zoster]

471

2699

1.79

29.70

2.1

1.8

37.54

38.88

u/l

0.71

406

2339

Hyperkalaemia

161

612

2.75

29.67

1.7

1.8

39.09

39.61

u/l

0.09

139

515

Seropositive rheumatoid arthritis, wide

685

4332

1.61

29.51

1.6

2.0

37.49

39.22

u/l

1.41

599

3794

Dialysis

141

505

2.97

29.44

1.6

2.0

39.93

39.81

u/l

0.02

135

449

Other and unspecified disorders of skin and subcutaneous tissue

203

867

2.46

29.41

2.3

1.9

41.85

38.51

u/l

1.56

179

760

Missing teeth due to accident, extraction or parodontitis

1474

10173

1.38

29.36

1.9

39.49

39.12

u/l

0.26

1275

8922

Microscopic polyangiitis

7.69

29.31

1.1

2.3

34.80

37.93

u/l

0.40

Neovascular glaucoma

140

501

2.96

29.20

2.8

2.0

40.78

38.77

u/l

0.45

125

445

Glaucoma secondary to other eye disorders

140

502

2.95

29.08

2.8

1.9

40.78

38.94

u/l

0.40

125

444

Diseases of spleen

226

4.16

29.05

2.1

2.0

43.29

38.09

u/l

0.80

207

conjunctival haemorrhage

228

1030

2.31

28.94

2.0

1.8

37.50

38.98

u/l

0.58

206

900

Other specified/unspecified necrotizing vasculopathies

166

4.81

28.90

2.2

2.1

36.87

38.63

u/l

0.27

146

Atypical facial pain

172

687

2.64

28.88

2.0

39.72

39.49

u/l

0.05

158

612

Glaucoma

1340

8323

1.40

28.82

2.1

1.8

39.95

38.87

u/l

1.11

1182

7203

Hypotension

398

2189

1.86

28.74

1.9

1.7

37.77

38.29

u/l

0.18

330

1848

Chronic ulcer of skin, not elsewhere classified

200

857

2.44

28.66

1.9

1.8

39.26

38.73

u/l

0.12

170

734

Exclusions for E4_PCOS_CONSORTIUM

1877

8880

1.34

28.64

1.9

2.0

39.74

39.75

u/l

0.01

1673

8060

Diabetic retinopathy, excluding more controls

705

2481

1.63

28.44

2.1

40.56

38.03

u/l

1.91

594

2131

Cardiodefibrillation

829

5506

1.53

28.25

2.0

1.8

37.06

38.53

u/l

1.11

676

4746

Postprocedural endocrine and metabolic disorders, not elsewhere classified

346

1835

1.94

28.20

1.9

2.0

38.56

40.02

u/l

0.67

311

1672

Coxarthrosis

1136

5241

1.45

28.16

1.9

2.0

38.82

39.30

u/l

0.33

998

4591

Inflammatory bowel disease

830

5534

1.53

28.10

1.7

2.0

38.37

39.46

u/l

0.89

730

4993

Other dialysis

120

405

3.20

28.07

1.8

2.0

42.21

38.37

u/l

1.12

114

361

Unspecified haematuria

1004

5730

1.47

28.06

1.7

1.9

37.46

38.63

u/l

1.04

867

4979

Injuries to the head

2894

14232

1.26

28.02

1.9

2.0

40.39

39.21

u/l

2.18

2552

12760

Paracetamol or NSAID medication

392

1037

1.93

27.96

1.9

2.0

38.05

38.24

u/l

0.06

351

918

Childhood asthma (age<16)

268

1005

2.14

27.93

2.0

1.2

42.04

38.81

u/l

1.72

246

937

Volume depletion

231

1060

2.25

27.92

2.2

1.7

37.06

39.27

u/l

0.70

199

905

Idiopathic gout

254

1215

2.17

27.84

1.8

1.7

36.05

37.92

u/l

0.71

214

1027

Major coronary heart disease event excluding revascularizations

1388

6713

1.39

27.75

1.9

37.15

39.72

u/l

4.34

1146

5946

Disorders of vitreous body and globe

1255

8690

1.41

27.74

2.1

1.9

39.78

39.39

u/l

0.27

1109

7599

Rash and other nonspecific skin eruption

269

1317

2.11

27.67

2.1

1.9

40.03

38.86

u/l

0.42

248

1168

Cholecystectomy

1784

11683

1.33

27.60

2.0

39.11

39.37

u/l

0.22

1592

10342

Primary biliary cholangitis (PBC)

233

3.95

27.60

2.3

2.0

46.84

40.27

u/l

1.62

209

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1410

10073

1.38

27.60

2.0

39.23

39.87

u/l

0.61

1275

9094

Hypo-osmolality and hyponatraemia

407

2269

1.82

27.58

1.5

1.8

40.09

39.69

u/l

0.12

345

1964

Other and unspecified rosacea

264

1288

2.13

27.55

2.0

1.9

40.37

39.68

u/l

0.21

238

1159

Pleural plaque

229

1055

2.24

27.49

1.6

35.11

37.94

u/l

1.17

200

868

Other and unspecified effects of external causes

717

4664

1.57

27.28

1.9

2.0

39.71

39.48

u/l

0.12

664

4222

Other diseases of lip and oral mucosa

1018

7113

1.45

27.13

2.0

40.80

39.34

u/l

1.36

907

6312

Other peripheral vascular diseases

242

1149

2.19

27.09

1.7

1.9

38.98

39.28

u/l

0.08

211

1023

Psychiatric diseases

2636

10444

1.27

27.08

1.9

2.0

39.06

39.29

u/l

0.22

2343

9354

Thrombocytopenia, unspecified

214

970

2.30

26.97

2.0

1.8

44.47

38.23

u/l

2.40

199

848

Other external causes of accidental injury

2187

8470

1.30

26.96

2.0

39.21

39.03

u/l

0.15

1952

7648

Menorrhagia

878

3247

1.52

26.93

2.0

40.04

39.99

u/l

0.03

785

2934

Malignant neoplasm, wide definition for exclusion

2320

10646

1.29

26.91

2.0

2.1

40.31

39.43

u/l

1.14

2091

9540

Disorders of vestibular function (Vertigo)

1151

8093

1.42

26.84

1.8

1.9

38.16

39.21

u/l

0.98

1008

7098

Disorders of orbit

151

588

2.71

26.79

1.9

2.1

40.04

39.94

u/l

0.02

136

525

Adverse effects, not elsewhere classified

523

3173

1.69

26.77

1.8

1.9

38.61

39.24

u/l

0.33

487

2866

Diffuse large B-cell lymphoma, helper endpoint

146

560

2.76

26.70

1.8

1.9

42.07

38.82

u/l

0.83

128

473

Diffuse large B-cell lymphoma

146

560

2.76

26.70

1.8

1.9

42.07

38.82

u/l

0.83

128

473

Diffuse large B-cell lymphoma, including Hilmo

146

560

2.76

26.70

1.8

1.9

42.07

38.82

u/l

0.83

128

473

Accidents

2184

8470

1.30

26.65

2.0

39.28

39.03

u/l

0.22

1946

7648

Other and unspecified drugs and medicaments

253

1230

2.14

26.64

1.9

38.16

38.94

u/l

0.23

219

1098

Other and unspecified nerve root and plexus disorders, also in other diseases

532

3249

1.68

26.57

2.0

1.9

40.38

39.75

u/l

0.32

473

2901

Pneumonia due to other infectious organisms, not elsewhere classified

118

407

3.09

26.42

1.9

41.80

39.18

u/l

0.54

111

357

Rosacea

332

1778

1.93

26.40

2.1

1.9

39.97

39.60

u/l

0.12

300

1600

Raynaud syndrome

262

1297

2.10

26.29

1.6

2.0

37.79

39.30

u/l

0.66

235

1174

Inflammatory diseases of female pelvic organs

1534

8412

1.36

26.28

1.9

2.0

40.01

39.76

u/l

0.19

1382

7617

Systemic lupus erythematosus, unspecified

122

432

3.04

26.25

1.6

2.0

40.70

39.96

u/l

0.15

108

386

Endometriosis

875

3444

1.51

26.23

1.9

2.0

39.25

39.82

u/l

0.32

779

3115

Other/unspecified seropositive rheumatoid arthritis

662

4271

1.58

26.22

1.5

2.0

37.34

39.28

u/l

1.65

580

3745

Diseases of oral cavity, salivary glands and jaws

1490

5638

1.37

26.07

1.8

1.9

38.52

38.93

u/l

0.31

1309

4953

Hypogonadotropic hypogonadism

122

435

3.03

25.94

2.1

2.0

38.31

38.93

u/l

0.12

117

398

Other viral diseases, not elsewhere classified

473

2812

1.71

25.86

1.9

40.35

39.14

u/l

0.58

441

2545

External causes of morbidity and mortality

1771

6705

1.34

25.82

2.0

38.87

39.04

u/l

0.14

1586

6057

Irregular menses

1219

6958

1.40

25.82

2.0

39.62

39.61

u/l

0.01

1115

6383

Spirochaetal infections, other/unspecified

256

1266

2.10

25.80

1.8

40.78

38.76

u/l

0.87

218

1132

Ethmoidectomy

367

2043

1.85

25.77

2.4

1.9

39.94

39.25

u/l

0.27

342

1833

Dentofacial anomalies [including malocclusion]

1812

11168

1.32

25.73

1.9

2.1

39.82

39.70

u/l

0.10

1676

10093

Collagenous colitis

262

1307

2.08

25.72

2.1

1.8

40.72

38.72

u/l

0.86

224

1171

Streptococcal septicaemia

231

1098

2.18

25.69

1.9

1.8

38.39

39.42

u/l

0.31

201

962

Other diseases of anus and rectum

713

4683

1.54

25.62

1.8

1.9

38.95

38.38

u/l

0.30

632

4085

Candidiasis

371

2076

1.84

25.56

2.2

1.9

41.48

39.23

u/l

1.20

332

1862

Allergic conjunctivitis

1472

10740

1.35

25.55

2.0

39.27

39.83

u/l

0.53

1333

9711

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

654

4234

1.58

25.53

1.5

2.0

37.38

39.25

u/l

1.55

575

3711

FESS (DNB20)

355

1963

1.86

25.49

2.4

1.9

40.12

39.30

u/l

0.34

330

1769

Gastric ulcer

414

2388

1.77

25.48

1.7

1.8

40.90

38.67

u/l

0.93

359

2041

Disorders of vitreous body

1213

8524

1.39

25.45

2.1

1.9

39.92

39.40

u/l

0.38

1074

7453

Other diseases of intestine

363

2019

1.85

25.43

2.0

1.9

37.32

38.29

u/l

0.44

317

1750

Gastroduodenal ulcer

580

3640

1.62

25.42

1.8

40.39

38.76

u/l

0.82

503

3121

Polyarteritis nodosa and related conditions

161

4.54

25.36

1.3

2.1

36.25

38.86

u/l

0.46

140

Noninfectious colitis NAS

362

2015

1.85

25.32

1.8

1.9

39.17

39.01

u/l

0.04

318

1808

Tuberculosis, IBD comorbidity

186

815

2.36

25.27

1.8

39.79

38.34

u/l

0.46

164

697

Fenamates

366

1355

1.87

25.26

2.0

39.43

38.15

u/l

0.53

327

1178

Diabetic nephropathy

423

2437

1.76

25.22

1.9

2.0

41.04

37.77

u/l

2.02

353

2066

Ankylosing spondylitis

249

1229

2.09

25.08

1.9

2.0

38.54

38.66

u/l

0.04

227

1108

Brachial plexus disorders

276

1415

2.02

25.04

1.8

2.1

39.96

39.20

u/l

0.28

259

1291

Psoriatic and enteropathic arthropathies

307

1629

1.94

25.02

1.6

2.0

39.43

39.70

u/l

0.09

282

1459

Idiopathic hypercalciuria

6.42

25.02

3.1

2.3

45.17

40.87

u/l

0.50

Benign neoplasm: Colon, unspecified

605

3867

1.60

25.01

1.8

39.32

38.73

u/l

0.29

517

3333

Diseases of inner ear

1321

9451

1.37

24.90

1.8

2.0

38.16

39.28

u/l

1.18

1160

8292

Other disorders of eyelid

1024

6916

1.43

24.85

1.8

38.92

39.10

u/l

0.10

892

5972

Strabismus

662

4310

1.56

24.85

1.9

2.0

38.34

39.36

u/l

0.65

602

3858

Disease of hard tissues of teeth, NOS

1431

5523

1.37

24.79

2.0

39.14

39.02

u/l

0.08

1305

4863

Drug-induced osteoporosis with pathological fracture

211

4.00

24.53

3.5

2.1

38.61

39.49

u/l

0.11

186

Hypoparathyroidism

122

448

2.89

24.39

2.3

2.0

38.77

40.21

u/l

0.28

102

390

Diseases of pulp and periapical tissues, including avohilmo

2732

11396

1.25

24.29

1.9

2.0

39.68

39.24

u/l

0.53

2422

10198

Other complications of surgical and medical care, not elsewhere classified

272

1402

2.00

24.28

1.9

37.84

39.38

u/l

0.69

249

1261

Ulcerative colitis

637

4146

1.57

24.27

1.8

2.0

38.31

39.35

u/l

0.68

555

3732

Caries of dentine, including avohilmo

2024

8036

1.30

24.19

1.9

39.09

39.07

u/l

0.01

1788

7132

Disorders of optic nerve, not elsewhere classified

266

3.56

24.12

2.1

40.15

39.53

u/l

0.10

232

Pollen allergy

474

2845

1.68

24.00

1.8

1.9

38.87

39.32

u/l

0.21

427

2636

Other and unspecified types of non-Hodgkin lymphoma, hilmo

134

520

2.72

24.00

1.6

1.8

41.19

38.73

u/l

0.60

113

451

Paralytic strabismus

203

945

2.24

23.99

1.8

36.13

38.75

u/l

1.00

180

824

Cardiac arrest

155

539

2.53

23.96

2.3

1.7

37.52

41.10

u/l

1.04

122

498

Methotrexate

320

1745

1.88

23.84

1.6

1.5

39.69

39.79

u/l

0.03

279

1526

Right bundle-branch block

107

369

3.04

23.83

3.4

1.6

36.22

40.51

u/l

1.16

321

Chronic tubulo-interstitial nephritis

123

459

2.82

23.73

2.6

2.0

39.02

39.99

u/l

0.20

116

411

Explicit bacterial Sepsis

264

1357

2.00

23.65

1.9

37.88

39.05

u/l

0.40

233

1190

Dental caries, including avohilmo

1883

7446

1.31

23.46

1.9

39.34

38.91

u/l

0.40

1659

6596

Tuberculosis, wide

189

861

2.27

23.43

1.8

1.7

39.91

38.10

u/l

0.63

166

734

GI-bleeding

727

4897

1.51

23.42

1.8

39.77

38.55

u/l

0.75

619

4235

Trigeminal neuralgia

177

788

2.34

23.36

1.8

1.9

39.40

39.80

u/l

0.10

158

692

Presence of other devices

522

3260

1.62

23.30

1.8

1.7

40.05

38.65

u/l

0.78

458

2775

Unspecified acute lower respiratory infection

389

2267

1.76

23.25

2.0

1.9

37.32

39.08

u/l

1.01

353

2020

Hernia

2377

12762

1.26

23.24

2.0

40.12

39.52

u/l

0.70

2072

11441

Other inflammatory liver diseases

197

919

2.23

23.20

2.0

1.9

44.70

38.80

u/l

2.97

178

822

Trochanteric bursitis

359

2047

1.80

23.19

1.9

2.0

39.90

39.23

u/l

0.23

313

1805

Fitting and adjustment of other devices

788

4865

1.48

23.16

1.9

1.8

39.11

38.86

u/l

0.11

694

4194

Other overlap syndromes

224

3.75

23.07

1.7

2.2

40.57

40.65

u/l

0.01

201

Gingivitis and periodontal diseases

2657

11073

1.25

23.04

1.9

2.0

39.19

39.37

u/l

0.17

2350

9892

Degenerative macular diseases

287

1535

1.92

22.88

1.8

39.57

37.92

u/l

0.65

246

1297

Conductive and sensorineural hearing loss

1936

10236

1.29

22.86

1.9

38.92

39.30

u/l

0.35

1714

8987

Hyperhidrosis

330

3.13

22.80

1.9

1.8

39.93

40.43

u/l

0.10

302

Other and unspecified tonsillitis

824

4784

1.47

22.79

2.1

38.58

39.67

u/l

0.86

766

4398

Other extrapyramidal and movement disorders in other diseases

582

3769

1.58

22.78

1.8

1.9

39.01

39.19

u/l

0.09

515

3299

Falls/tendency to fall

2846

11603

1.24

22.76

2.0

39.63

39.33

u/l

0.32

2540

10475

Exposure to other specified factors

1903

13740

1.28

22.75

2.0

40.12

39.36

u/l

0.90

1703

12321

Viral hepatitis, IBD co-morbidity

117

432

2.78

22.71

1.7

2.4

47.27

40.38

u/l

1.62

106

404

Hodgkin lymphoma, hilmo

107

382

2.99

22.65

1.8

2.0

44.65

38.49

u/l

1.58

338

Herpesviral [herpes simplex] infections

314

1735

1.86

22.63

2.2

1.9

40.13

39.35

u/l

0.28

282

1567

Agranulocytosis

301

1644

1.89

22.58

1.8

40.79

38.83

u/l

0.72

271

1456

Lichen simplex chronicus and prurigo

185

852

2.26

22.51

1.8

1.9

39.11

38.96

u/l

0.03

160

755

Anaemia in chronic diseases classified elsewhere

277

3.37

22.49

1.4

1.9

41.19

38.97

u/l

0.36

248

Deviated nasal septum

781

5379

1.47

22.42

1.9

2.0

39.47

39.41

u/l

0.03

704

4744

Ovarian cyst

881

3524

1.46

22.41

1.9

2.0

38.42

39.79

u/l

1.25

798

3190

Iron deficiency anaemia secondary to blood loss (chronic)

385

2261

1.74

22.37

1.8

1.9

38.21

39.02

u/l

0.28

336

1980

Dental operations

1550

6037

1.33

22.29

1.8

1.9

38.71

39.06

u/l

0.27

1368

5278

Multiple myeloma, including Hilmo

129

510

2.65

22.19

1.3

1.8

34.33

38.91

u/l

1.43

118

425

Disorders of refraction and accommodation

660

4404

1.52

21.97

2.1

2.0

39.66

39.79

u/l

0.06

598

3992

Other sleep disorders

285

1542

1.90

21.93

2.4

1.8

40.89

39.45

u/l

0.58

260

1368

Intracranial injury

1400

10064

1.33

21.87

1.8

1.9

40.73

38.86

u/l

2.52

1227

8943

Polyuria

529

3384

1.59

21.85

1.7

1.9

37.12

38.51

u/l

0.86

461

2943

Benign neoplasm of other and ill-defined parts of digestive system

449

2768

1.66

21.76

1.9

38.73

39.17

u/l

0.18

388

2407

Other infectious diseases

240

1233

2.01

21.68

2.3

1.8

38.15

38.73

u/l

0.16

216

1080

Other diseases of the digestive system

719

4911

1.49

21.66

1.8

39.73

38.59

u/l

0.69

612

4251

Propionic acid derivatives

649

2124

1.55

21.64

1.9

39.63

38.24

u/l

0.92

575

1851

Chronic nephritic syndrome

132

536

2.60

21.61

1.6

1.9

39.98

39.00

u/l

0.17

120

470

Sensorineural hearing loss

1813

9637

1.29

21.60

1.9

38.70

39.20

u/l

0.48

1605

8418

Cutaneous abscess, furuncle and carbuncle

645

4318

1.52

21.59

2.1

1.9

39.27

39.11

u/l

0.07

568

3872

Other disorders of bone

509

3238

1.60

21.58

2.0

1.9

39.40

39.21

u/l

0.08

460

2932

Heart failure and hypertrophic cardiomyopathy

225

3.64

21.48

2.9

2.1

36.11

40.11

u/l

0.56

197

IgA nephropathy (IgA glomerulonephritis)

339

3.09

21.48

1.6

2.0

35.78

38.26

u/l

0.54

303

Unknown and unspecified causes of morbidity

172

782

2.26

21.41

2.0

1.7

37.65

39.35

u/l

0.57

163

698

Corneal ulcer

456

2831

1.64

21.40

2.2

2.0

41.32

39.15

u/l

1.31

415

2531

Other specified and unspecified retinal disorders

120

468

2.72

21.38

1.9

2.0

41.02

38.79

u/l

0.57

108

413

Nonorganic sleeping disorders, excluding more controls

476

2986

1.62

21.34

2.0

38.87

39.43

u/l

0.28

441

2731

Motor neuron disease (with DMD)

191

3.80

21.29

1.7

2.0

38.24

39.05

u/l

0.12

161

Other disorders of patella

425

2596

1.67

21.26

2.1

38.91

39.46

u/l

0.23

386

2352

Motor neuron disease

187

3.83

21.19

1.7

1.9

38.06

38.96

u/l

0.14

157

Myocardial infarction

1065

5460

1.39

21.12

1.8

1.9

36.91

39.58

u/l

3.58

873

4827

Abnormal findings on examination of urine, without diagnosis

135

561

2.53

20.96

1.7

1.9

41.63

38.85

u/l

0.69

111

501

All influenza (not pneumonia)

357

2092

1.74

20.90

2.1

1.9

39.07

39.55

u/l

0.17

319

1864

Chronic hepatitis, not elsewhere classified

120

474

2.68

20.87

1.9

2.0

47.75

38.91

u/l

3.04

110

420

Kidney transplant status

162

732

2.32

20.78

1.5

2.0

38.08

38.90

u/l

0.19

156

655

Diabetic maculopathy, excluding more controls

274

1492

1.89

20.70

1.9

41.80

39.31

u/l

0.86

233

1340

Gonarthrosis,primary

2184

10809

1.26

20.64

1.9

2.0

38.70

39.56

u/l

1.13

1900

9520

Other specified/unspecified inflammatory spondylopathies

150

658

2.38

20.57

1.8

2.2

39.38

39.10

u/l

0.07

135

599

Injury, poisoning and certain other consequences of external causes

1417

5377

1.33

20.55

1.9

2.0

38.35

39.07

u/l

0.68

1266

4845

Elevated blood glucose level

224

1149

2.01

20.40

2.1

1.9

38.41

38.83

u/l

0.09

190

1023

Macular cyst

100

365

2.92

20.37

2.5

1.9

38.18

38.92

u/l

0.14

320

Triptan medication for migraine, min. 3 purchases

1445

8483

1.31

20.20

2.1

2.0

39.30

39.73

u/l

0.39

1353

7751

Malignant neoplasm

2175

10352

1.25

20.18

1.9

2.1

39.93

39.41

u/l

0.52

1955

9262

Drug-induced osteoporosis

167

4.06

20.17

6.3

2.1

35.72

39.74

u/l

0.67

147

Monoarthritis, not elsewhere classified

127

523

2.54

20.07

1.7

2.0

38.49

37.76

u/l

0.16

119

467

Idiopathic thrombocytopenic purpura

103

385

2.84

19.99

2.9

1.9

45.46

38.89

u/l

1.38

343

Nasal polyp

460

2911

1.61

19.97

2.0

1.9

38.62

39.23

u/l

0.28

418

2554

Other keratitis

290

1627

1.83

19.91

1.7

1.9

38.95

39.18

u/l

0.07

259

1456

Cellulitis

537

3522

1.55

19.89

2.2

1.9

39.14

39.20

u/l

0.02

465

3128

Papulosquamous disorders

960

7018

1.39

19.83

2.0

39.26

39.25

u/l

0.01

852

6225

Amyloidosis

251

3.32

19.83

1.3

2.0

37.22

39.21

u/l

0.30

221

Dermatitis due to substances taken internally

156

707

2.29

19.78

2.1

2.0

38.39

38.86

u/l

0.10

140

631

Other enthesopathy of foot (+metatarsalgia)

268

1472

1.87

19.75

2.2

2.0

38.83

39.29

u/l

0.14

238

1331

Other shoulder lesions

246

1316

1.92

19.70

1.9

2.0

40.04

38.87

u/l

0.39

219

1203

Other specified/unspecified soft tissue disorders

135

576

2.44

19.68

2.1

1.9

39.55

38.18

u/l

0.37

129

510

Benign neoplasm of other and unspecified endocrine glands

346

2050

1.73

19.67

1.9

38.92

39.35

u/l

0.14

310

1828

Disorder of lipoprotein metabolism, unspecified

299

1698

1.80

19.63

1.9

1.8

37.13

39.28

u/l

0.93

235

1466

Lesion of ulnar nerve

354

2114

1.71

19.47

2.2

1.9

39.31

39.65

u/l

0.11

327

1885

Isolated proteinuria

100

374

2.84

19.43

1.8

2.0

43.56

38.14

u/l

1.35

335

Calculus of kidney and ureter

702

4881

1.46

19.42

2.2

1.9

38.02

38.82

u/l

0.48

630

4273

Anti-inflammatory and antirheumatic products, non-steroids

636

2124

1.52

19.39

1.9

39.66

38.24

u/l

0.93

565

1851

Corticotropin deficiency

123

4.67

19.34

2.0

2.2

39.96

38.95

u/l

0.14

111

Cluster headache, wide

121

497

2.55

19.27

1.7

2.0

38.30

40.43

u/l

0.61

111

457

Oter anti-inflammatory and antirheumatic agents, non-steroids

482

1671

1.61

19.27

1.9

2.0

39.52

37.84

u/l

0.92

424

1420

Diseases of pulp and periapical tissues and dental caries

1654

6617

1.29

19.19

1.8

1.9

38.65

38.89

u/l

0.18

1466

5842

Malignant immunoproliferative diseases

128

4.49

19.09

1.6

2.3

40.23

38.85

u/l

0.14

115

COPD, hospital admissions

991

6168

1.37

19.08

1.7

1.8

37.29

38.55

u/l

1.09

843

5302

Metatarsalgia

250

1360

1.89

19.04

2.3

2.0

38.72

39.13

u/l

0.11

222

1233

Early onset COPD

534

3534

1.54

19.02

2.0

1.9

38.36

39.11

u/l

0.37

456

3094

Type 1 diabetes, wide definition, subgroup 1

494

3212

1.56

18.92

2.1

1.9

43.99

39.54

u/l

3.88

439

2948

Other abnormal uterine and vaginal bleeding

543

2556

1.55

18.90

1.9

2.0

41.58

40.04

u/l

1.07

464

2275

Sequelae of external causes of morbidity and mortality

603

4097

1.50

18.85

1.9

38.34

39.06

u/l

0.37

544

3592

Cardiomyopathy, Hypertrophic obstructive

183

3.68

18.83

3.2

1.7

39.34

41.08

u/l

0.19

165

Myelodysplastic syndrome, including Hilmo

290

3.05

18.80

1.5

2.0

31.81

39.99

u/l

2.98

237

Injuries to the thorax

1046

7807

1.35

18.77

2.0

1.9

40.76

38.97

u/l

1.87

927

6851

Nephrotic syndrome

104

404

2.72

18.74

1.5

2.0

40.68

39.37

u/l

0.22

357

COPD, early/later onset

998

6217

1.37

18.73

1.7

1.8

37.36

38.50

u/l

0.94

849

5344

Fissure and fistula of anal and rectal regions

578

3898

1.51

18.73

1.9

2.0

39.18

38.87

u/l

0.14

522

3450

Ascites

186

921

2.08

18.72

1.7

1.8

43.32

38.69

u/l

1.54

160

797

Neuralgia and neuritis, unspecified

149

679

2.28

18.69

2.0

38.25

38.70

u/l

0.09

131

609

Acute generalized exanthematous pustulosis

136

598

2.38

18.65

2.2

2.0

37.05

38.86

u/l

0.48

121

530

Viral pneumonia (unknown virus, not influenza)

190

951

2.07

18.62

2.4

1.9

36.24

38.81

u/l

0.94

172

850

Dermatographic urticaria

194

979

2.05

18.62

1.6

2.0

42.81

38.89

u/l

1.83

183

894

Multiple myeloma and malignant plasma cell neoplasms

133

580

2.40

18.57

1.3

1.9

34.36

37.94

u/l

1.00

122

498

Other and unspecified myopathies

219

1152

1.96

18.55

1.7

1.8

40.31

38.51

u/l

0.57

195

1002

Other/unspecified synovitis and tenosynovitis

288

1649

1.79

18.46

2.0

38.17

39.19

u/l

0.36

258

1478

Sacroiliitis, not elsewhere classified

143

644

2.31

18.44

1.9

2.2

37.27

38.16

u/l

0.23

133

597

Recurrent aphthous stomatitis , including avohilmo

353

2138

1.69

18.43

2.0

1.9

39.61

39.07

u/l

0.21

320

1919

Heartburn

270

1518

1.82

18.41

2.0

1.9

39.15

39.16

u/l

0.00

233

1341

Cluster headache, strict

115

473

2.55

18.31

1.7

2.0

38.30

40.56

u/l

0.62

105

438

Calcific aortic valvular stenosis, operated

590

3887

1.49

18.26

1.7

37.93

37.92

u/l

0.00

487

3260

Calcific aortic valvular stenosis

590

3887

1.49

18.26

1.7

37.93

37.92

u/l

0.00

487

3260

Calcific aortic valvular stenosis, diagnosis (helper)

589

3882

1.49

18.19

1.7

37.93

u/l

0.00

486

3256

Operations 2 for CAVS

589

3882

1.49

18.19

1.7

37.93

u/l

0.00

486

3256

Retention of urine

743

4312

1.43

18.18

1.5

1.8

37.81

38.24

u/l

0.19

641

3731

Injuries to the abdomen, lower back, lumbar spine and pelvis

902

6546

1.38

18.16

1.9

40.30

39.10

u/l

0.94

780

5765

Valvular operations

286

1645

1.77

17.94

2.0

1.6

37.95

39.16

u/l

0.42

241

1462

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

5.21

17.92

1.4

2.0

36.37

37.49

u/l

0.10

Extrapyramidal and movement disorders

856

6249

1.39

17.88

1.7

1.9

38.80

38.96

u/l

0.09

753

5433

Covid-19 suspected case

536

3596

1.52

17.87

1.9

2.0

38.48

39.38

u/l

0.53

497

3262

Calcific aortic valvular stenosis, including rheumatic fever

589

3895

1.48

17.81

1.7

37.93

37.94

u/l

0.00

486

3264

Other and unspecified disorders of white blood cells

127

555

2.40

17.74

2.6

2.0

41.03

38.92

u/l

0.38

111

489

Mature T/NK-cell lymphomas, hilmo

163

3.83

17.64

1.3

2.1

43.68

39.19

u/l

0.68

144

Other infectious diseases

195

1004

2.00

17.62

2.3

1.8

37.45

38.84

u/l

0.39

174

872

Diseases of external ear

786

5673

1.40

17.62

1.7

1.9

39.55

39.04

u/l

0.30

674

5016

Superficial injury of lower leg

595

4087

1.48

17.60

1.9

40.15

39.37

u/l

0.41

530

3640

Stomatitis and related lesions

477

3139

1.55

17.50

1.9

39.79

39.25

u/l

0.26

431

2813

Other diseases of stomach and duodenum

170

837

2.10

17.46

2.1

1.8

38.86

39.33

u/l

0.11

150

720

Retinal vascular occlusion

267

1521

1.80

17.45

1.9

1.7

38.90

37.87

u/l

0.36

221

1288

Retinal vascular disorders

270

1544

1.79

17.40

1.9

1.7

38.99

37.83

u/l

0.42

223

1306

Other chronic obstructive pulmonary disease, including avohilmo

1193

7559

1.32

17.38

1.7

1.9

37.88

38.69

u/l

0.65

1022

6528

Neuromuscular dysfunction of bladder

231

1265

1.88

17.29

1.6

1.9

37.44

39.10

u/l

0.61

202

1106

Haemorrhoids and perianal venous thrombosis

714

5072

1.42

17.29

1.8

1.9

40.12

38.69

u/l

1.05

621

4416

Pain associated with micturition

286

1669

1.76

17.21

1.6

1.9

37.01

39.49

u/l

1.26

247

1478

Urolithiasis

734

5260

1.41

17.19

2.2

1.9

37.95

38.68

u/l

0.44

656

4592

Glaucoma suspect

815

5947

1.39

17.12

2.2

1.9

40.34

39.02

u/l

1.04

722

5140

Spondylolisthesis/Spondylolysis

431

2788

1.57

17.10

2.1

2.0

39.81

39.12

u/l

0.30

392

2464

Thyrotoxicosis, other and/or unspecified

479

3171

1.54

17.08

2.2

2.0

38.88

39.21

u/l

0.13

426

2821

Coeliac disease

302

1796

1.72

16.96

1.9

41.87

39.21

u/l

1.40

279

1622

Otalgia

205

1088

1.94

16.96

2.2

2.0

41.26

39.90

u/l

0.50

182

988

Panic disorder

358

2221

1.64

16.95

1.8

2.0

39.68

39.40

u/l

0.09

328

2053

Sequelae with surgical and medical care as external cause

477

3165

1.54

16.87

1.9

38.10

39.05

u/l

0.46

437

2760

Type 1 diabetes

576

3958

1.47

16.86

2.1

1.9

43.61

39.51

u/l

4.02

514

3607

Cerebral palsy and other paralytic syndromes

276

1604

1.76

16.86

1.7

1.9

37.87

39.13

u/l

0.48

245

1431

COPD-related respiratory insufficiency

265

1523

1.78

16.82

1.9

1.7

34.67

38.05

u/l

1.78

224

1281

851

5735

1.38

16.82

2.0

1.8

39.58

38.31

u/l

0.97

731

4867

Generalized anxiety disorder

375

2360

1.62

16.73

1.9

37.45

39.23

u/l

1.25

349

2184

Restless leg syndrome

334

2050

1.67

16.65

1.8

1.9

39.18

39.46

u/l

0.11

291

1819

Lung diseases due to external agents

306

1833

1.70

16.65

1.9

1.8

40.09

38.02

u/l

0.72

276

1567

Alcoholic liver disease

249

1412

1.81

16.63

1.5

1.9

48.21

38.06

u/l

6.70

228

1229

Seborrhoeic dermatitis

237

1324

1.84

16.63

1.6

1.9

39.11

38.69

u/l

0.11

218

1168

COPD related to multimorbidity

837

5184

1.38

16.61

1.7

1.8

36.71

38.45

u/l

1.57

698

4427

IBD patients in KELA-register

563

3873

1.48

16.59

1.7

2.0

37.93

39.30

u/l

0.98

496

3507

Suppurative and necrotic conditions of lower respiratory tract

149

713

2.17

16.58

2.0

1.9

36.17

38.19

u/l

0.70

131

628

Pleural plaque with presence of asbestos

170

853

2.06

16.57

1.5

1.6

34.90

36.65

u/l

0.50

145

704

Other abnormalities of plasma proteins

195

3.44

16.53

2.1

2.2

41.65

38.68

u/l

0.41

174

Herpesviral [herpes simplex] infections

597

4156

1.46

16.52

2.1

2.0

40.07

39.56

u/l

0.27

541

3762

Behavioural syndromes associated with physiological disturbances and physical factors

2292

13474

1.21

16.45

2.0

40.20

39.52

u/l

0.89

2065

12100

Other/unspecified rheumatoid arthritis

292

1736

1.72

16.44

1.7

1.8

39.07

39.21

u/l

0.04

261

1510

Persons with potential health hazards related to communicable diseases

900

6649

1.36

16.43

2.0

37.51

39.81

u/l

3.19

829

6123

Phlebitis and thrombophlebitis (not including DVT)

536

3661

1.49

16.41

1.9

38.96

39.01

u/l

0.02

476

3238

Mucosal proctocolitis

324

1982

1.67

16.34

1.7

2.0

38.58

39.15

u/l

0.22

281

1803

Actinic keratosis

769

5178

1.39

16.29

2.0

1.7

39.38

38.24

u/l

0.78

655

4364

Complications of internal orthopaedic prosthetic devices, implants and grafts

486

3260

1.51

16.27

1.9

1.8

39.77

38.95

u/l

0.36

423

2805

Type 1 diabetes, wide definition

505

3409

1.50

16.25

2.1

1.9

43.75

39.44

u/l

3.79

448

3124

Sixth [abducent] nerve palsy

103

427

2.54

16.23

1.8

1.9

35.95

39.73

u/l

0.99

377

Diabetic retinopathy

824

3752

1.39

16.18

2.0

2.1

40.44

37.81

u/l

2.41

684

3204

Flat foot [pes planus] (acquired)

233

1306

1.83

16.16

2.0

42.62

39.85

u/l

1.23

207

1163

Other and unspecified coagulation defects

148

716

2.15

16.07

1.9

2.1

38.88

39.34

u/l

0.09

129

645

Injuries to the ankle and foot

1731

12470

1.24

16.07

2.0

39.96

39.45

u/l

0.49

1561

11275

Ankylosing spondylitis, ICD10

243

1385

1.81

16.03

1.9

2.0

38.58

39.42

u/l

0.30

221

1247

Dislocation, sprain and strain of joints and ligaments at neck level

375

2388

1.60

16.01

1.7

1.9

38.99

39.03

u/l

0.01

336

2183

Other/unspecified enthesopathies of lower limb, excluding foot

186

975

1.96

15.99

1.9

2.0

40.79

38.82

u/l

0.68

171

887

Other coagulation defects

198

1061

1.92

15.96

2.0

39.05

38.86

u/l

0.04

171

959

Allergic urticaria

215

1183

1.87

15.90

2.2

1.9

39.36

39.05

u/l

0.08

192

1077

Psoriatic arthropathies

249

1430

1.78

15.90

1.6

1.9

40.31

39.29

u/l

0.34

231

1276

Atopic dermatitis

1391

9014

1.28

15.90

1.9

2.0

39.78

39.47

u/l

0.25

1271

8184

Thyrotoxicosis

601

4221

1.45

15.88

2.1

2.0

38.90

39.53

u/l

0.32

534

3753

6-mercaptopurine

352

2.66

15.88

1.6

41.55

41.19

u/l

0.06

317

Stroke, excluding SAH

1336

7663

1.28

15.87

1.6

1.9

37.05

39.15

u/l

2.98

1110

6652

Cervicocranial syndrome

259

1505

1.76

15.85

2.0

1.9

42.58

38.50

u/l

2.49

233

1345

Endometriosis of pelvic peritoneum

395

2430

1.58

15.76

1.9

2.1

38.20

39.78

u/l

0.86

349

2221

Skin changes due to chronic exposure to nonionizing radiation

788

5339

1.38

15.69

2.0

1.7

39.26

38.32

u/l

0.61

673

4511

Ischaemic Stroke, excluding all haemorrhages

1241

7204

1.29

15.69

1.6

1.9

36.64

39.11

u/l

3.93

1029

6233

Glaucoma-related operations

147

716

2.13

15.65

1.9

1.8

37.27

39.31

u/l

0.59

130

618

Allergic contact dermatitis

333

2075

1.64

15.60

1.9

2.0

39.13

39.66

u/l

0.19

301

1882

Other disorders of veins

955

7199

1.33

15.59

2.0

1.9

39.85

39.40

u/l

0.28

818

6383

Sleep disorders

2200

13203

1.21

15.58

2.0

39.92

39.54

u/l

0.41

1987

11864

Hallux valgus (acquired)

724

3755

1.40

15.56

2.0

40.23

39.76

u/l

0.25

642

3328

Bipolar affective disorders

451

3012

1.52

15.46

1.7

2.0

39.19

39.42

u/l

0.10

401

2772

Psoriasis

679

4898

1.41

15.40

1.8

2.0

38.97

39.30

u/l

0.16

607

4349

Guillain-Barre syndrome

204

3.28

15.35

1.9

2.2

32.43

39.43

u/l

1.77

184

Transient ischemic attack

1150

7223

1.30

15.34

1.7

1.9

38.26

39.13

u/l

0.77

988

6261

Oesophageal varices

120

545

2.30

15.34

2.1

1.9

52.68

38.60

u/l

6.08

105

478

COPD, hospital admission 2, with asthma infections

672

4135

1.41

15.30

1.8

37.10

38.57

u/l

1.06

569

3529

Use of pramipexole

511

3511

1.48

15.25

1.9

39.59

39.45

u/l

0.06

443

3070

Mouth breathing

937

7102

1.33

15.23

2.1

2.0

39.24

39.21

u/l

0.02

839

6313

Third [oculomotor] nerve palsy

226

3.13

15.23

1.6

2.2

34.31

39.40

u/l

1.34

199

Inflammatory bowel disease, strict (require KELA)

563

3939

1.45

15.22

1.7

2.0

37.93

39.36

u/l

1.06

496

3574

Amyloidosis, other/unspecified

210

3.21

15.21

1.3

1.9

38.60

38.35

u/l

0.03

187

Injuries to the neck

541

3758

1.46

15.20

1.9

40.04

39.16

u/l

0.44

484

3384

Crohn disease

322

2011

1.64

14.98

1.6

2.0

37.96

39.11

u/l

0.52

289

1829

Special screening examination for neoplasms

134

639

2.16

14.98

1.9

1.7

38.72

39.85

u/l

0.24

114

560

Any event in cancer register

2311

11375

1.20

14.84

1.9

2.1

39.86

39.44

u/l

0.42

2072

10217

Familial hypercholesterolemia

311

1928

1.64

14.84

1.6

1.7

36.74

38.74

u/l

0.93

254

1648

L04AC Interleukin inhibitors

170

891

1.98

14.76

1.4

2.1

38.75

39.46

u/l

0.18

157

809

Other follicular disorders

198

1089

1.87

14.75

2.1

2.0

38.48

39.26

u/l

0.22

186

996

Stroke, including SAH

1409

8162

1.26

14.64

1.6

1.9

37.20

39.22

u/l

2.94

1170

7109

Systemic atrophies primarily affecting the central nervous system

117

537

2.27

14.58

1.6

1.9

38.08

38.80

u/l

0.17

106

466

Other and unspecified disorders of vitreous body

948

7152

1.32

14.56

2.1

1.9

39.60

39.46

u/l

0.07

832

6233

Cardiac murmurs and other cardiac sounds

191

1028

1.87

14.49

2.3

1.8

37.75

39.83

u/l

0.81

170

935

Faecal incontinence

212

1196

1.82

14.45

1.9

38.68

39.49

u/l

0.22

188

1050

Atopic dermatitis, strict definition with reimbursement

691

4871

1.39

14.44

1.9

2.0

39.73

39.48

u/l

0.13

634

4481

Benign paroxysmal vertigo

659

4784

1.40

14.42

1.6

1.9

37.36

39.18

u/l

1.41

567

4170

Tuberculosis of other organs

227

3.03

14.41

1.7

2.0

39.14

38.06

u/l

0.16

199

Osteomyelitis

164

856

1.98

14.38

2.6

1.8

41.05

38.11

u/l

0.86

143

746

Allergic purpura

402

2.48

14.36

1.8

2.2

37.60

39.15

u/l

0.31

360

Spontaneous rupture of synovium and tendon

196

1083

1.86

14.33

1.5

1.9

41.27

38.89

u/l

0.75

169

952

Thyroiditis

190

1042

1.88

14.31

2.3

2.0

36.88

39.75

u/l

1.26

174

946

Diseases of male genital organs

1180

4631

1.30

14.30

1.9

2.1

39.33

39.25

u/l

0.04

1048

4123

Speech disturbances, not elsewhere classified

207

1164

1.82

14.28

1.7

1.8

37.10

38.71

u/l

0.43

172

1015

Generalized skin eruption due to drugs and medicaments

116

536

2.26

14.25

2.3

2.0

37.37

39.07

u/l

0.38

102

476

Alzheimer disease, including avohilmo

340

3692

0.64

14.18

1.5

1.6

37.09

38.28

u/l

0.39

266

3074

Injuries to the shoulder and upper arm

2008

13465

1.21

14.17

1.9

2.0

40.34

39.31

u/l

1.39

1789

11962

Granuloma annulare

182

3.31

14.16

1.8

1.9

37.79

39.26

u/l

0.20

162

Charcot foot

192

3.21

14.15

3.1

1.9

42.88

39.53

u/l

0.41

175

Dissociative [conversion] disorders

105

466

2.34

14.13

1.6

2.2

39.84

38.74

u/l

0.24

434

Nonorganic sleeping disorders

476

3276

1.48

14.10

2.0

38.87

39.28

u/l

0.19

441

2982

Postmenopausal osteoporosis with pathological fracture

149

760

2.02

13.98

2.4

1.8

42.24

39.45

u/l

0.74

115

654

Other diseases of arteries and capillaries

210

1194

1.80

13.97

2.2

1.8

38.54

39.28

u/l

0.19

189

1039

Exophthalmic conditions

130

3.77

13.77

1.8

2.4

41.02

39.29

u/l

0.18

119

Vitamin deficiency

125

602

2.15

13.75

1.5

1.9

39.42

38.84

u/l

0.12

116

533

Vitamin deficiency, wide

125

602

2.15

13.75

1.5

1.9

39.42

38.84

u/l

0.12

116

533

Injuries to the wrist and hand

2459

14448

1.19

13.73

2.0

40.01

39.29

u/l

0.98

2219

12916

Other strabismus

493

3421

1.46

13.69

2.0

39.17

39.65

u/l

0.21

450

3097

Ganglion

480

3327

1.46

13.68

2.1

2.0

42.40

39.28

u/l

2.93

439

2997

Achilles tendinitis

250

1501

1.70

13.66

2.0

38.96

39.39

u/l

0.13

227

1339

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

391

2606

1.53

13.65

1.8

2.0

38.44

39.41

u/l

0.46

343

2364

Tuberculosis of other organs, strict

251

2.84

13.58

1.7

2.1

39.50

38.45

u/l

0.16

219

Astigmatism

153

794

1.98

13.58

1.8

1.9

39.82

39.65

u/l

0.04

141

713

Chronic lymphocytic leukaemia

297

2.68

13.58

1.7

1.9

43.10

39.47

u/l

0.64

248

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

297

2.68

13.58

1.7

1.9

43.10

39.47

u/l

0.64

248

Chronic lymphocytic leukaemia, helper endpoint

297

2.68

13.58

1.7

1.9

43.10

39.47

u/l

0.64

248

Diabetic neuropathy

277

1704

1.66

13.56

1.9

2.0

41.68

37.37

u/l

2.29

233

1437

Post-traumatic stress disorder

196

1102

1.82

13.51

2.1

38.78

39.23

u/l

0.14

178

1035

Artificial joint operation, meniscal resection

2182

11908

1.20

13.44

2.0

39.36

39.47

u/l

0.09

1916

10519

Personality disorders, excluding more controls

588

4236

1.40

13.44

1.9

2.1

40.83

39.55

u/l

0.75

523

3905

Other disorders of nervous system

170

919

1.91

13.44

2.2

1.9

39.86

38.65

u/l

0.36

147

814

Seropositive rheumatoid arthritis, strict definition

356

2336

1.55

13.43

1.4

2.0

37.00

39.59

u/l

1.56

312

2065

Viral infections of the central nervous system

190

1063

1.84

13.43

2.0

38.57

39.35

u/l

0.23

174

960

Hyperplasia of prostate

777

3277

1.36

13.42

1.8

1.9

36.60

38.16

u/l

1.19

672

2848

Other juvenile arthritis

438

2.33

13.40

2.0

2.1

40.57

39.00

u/l

0.31

417

Postmenopausal bleeding

615

2345

1.42

13.38

2.0

2.1

39.76

40.74

u/l

0.55

535

2067

Other disorders of cornea

226

1329

1.74

13.38

1.9

41.00

38.76

u/l

0.88

205

1179

Need for other prophylactic measures

157

829

1.96

13.37

2.8

2.0

35.99

39.33

u/l

1.69

144

737

Abnormal blood-pressure reading, without diagnosis

110

509

2.23

13.37

1.6

1.9

40.52

39.83

u/l

0.13

456

Acute pharyngitis

335

2149

1.57

13.36

1.8

2.1

37.41

40.02

u/l

1.74

309

1957

Other symptoms and signs involving the urinary system

241

1443

1.71

13.32

1.8

37.21

38.96

u/l

0.59

223

1246

Visual field defects

200

1139

1.80

13.28

1.7

1.8

36.79

38.65

u/l

0.67

177

990

Nontoxic multinodular goitre

430

2938

1.49

13.27

1.8

1.9

41.28

39.20

u/l

1.18

379

2544

Respiratory tuberculosis, bacteriologically and histologically confirmed

199

3.07

13.27

1.6

2.0

43.96

37.93

u/l

1.25

173

Dermatophytosis

304

1932

1.61

13.23

2.1

1.8

38.63

38.76

u/l

0.03

267

1700

Gluteal tendinitis

110

513

2.23

13.20

2.4

2.1

37.89

38.33

u/l

0.08

103

461

Hepatic failure, not elsewhere classified

105

481

2.28

13.20

2.5

2.0

47.30

39.48

u/l

1.78

426

Benign neoplasm: Transverse colon

251

1527

1.68

13.11

2.4

1.8

38.98

38.55

u/l

0.11

218

1314

Persons encountering health services for specific procedures, not carried out

206

1188

1.78

13.08

1.9

40.35

39.46

u/l

0.25

182

1072

Respiratory tuberculosis, confirmed

190

3.11

13.07

1.7

2.0

43.96

37.43

u/l

1.40

164

Peripheral artery disease

884

5391

1.32

13.05

1.8

37.80

38.84

u/l

0.69

732

4612

Tuberculosis

138

702

2.02

13.01

1.7

1.8

40.15

38.30

u/l

0.54

122

599

Psoriasis vulgaris

438

3018

1.48

12.98

1.9

38.87

39.30

u/l

0.18

391

2686

Multiple myeloma

269

2.72

12.94

1.2

2.0

34.18

38.98

u/l

1.03

226

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

269

2.72

12.94

1.2

2.0

34.18

38.98

u/l

1.03

226

Atherosclerosis, excluding cerebral and coronary sclerosis

822

4942

1.33

12.93

1.8

1.7

38.00

38.68

u/l

0.38

680

4203

Other noninfective disorders of lymphatic vessels and lymph nodes

108

505

2.23

12.93

2.0

38.30

39.34

u/l

0.21

452

Misadventures to patients during surgical and medical care

327

2124

1.57

12.92

2.0

1.9

39.89

39.55

u/l

0.11

293

1883

Hypocalcemia

306

2.63

12.91

1.8

2.2

41.50

39.31

u/l

0.34

272

Autonomic disorders

294

2.66

12.87

1.6

2.1

34.00

38.71

u/l

1.19

263

Persistent mood disorders

442

3054

1.47

12.87

1.9

2.0

38.82

39.30

u/l

0.20

390

2734

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

102

467

2.28

12.85

2.7

2.0

38.28

39.60

u/l

0.28

407

Ulcerative colitis (strict definition, require KELA)

398

2698

1.50

12.82

1.8

2.0

38.35

39.44

u/l

0.54

350

2443

Etanercept

175

970

1.86

12.80

1.5

2.1

37.96

39.49

u/l

0.53

160

885

Paralytic ileus and intestinal obstruction

541

3875

1.41

12.79

1.7

1.9

39.03

38.72

u/l

0.13

469

3351

Trigger finger

332

2168

1.56

12.79

1.8

2.0

41.09

39.54

u/l

0.78

301

1946

Pyogenic arthritis

153

812

1.93

12.74

2.1

1.9

36.05

38.58

u/l

0.82

127

717

Epilepsy

635

4658

1.37

12.74

1.8

1.9

39.78

39.51

u/l

0.11

572

4140

Excessive attrition of teeth

1335

10824

1.24

12.74

1.9

2.0

39.38

39.47

u/l

0.06

1214

9755

Cluster headache, wide,, including avohilmo

149

787

1.96

12.72

1.7

2.1

37.80

39.66

u/l

0.60

137

714

Viral infections of the central nervous system

200

1155

1.78

12.70

2.0

38.59

39.35

u/l

0.23

183

1045

Insomnia

2121

13049

1.19

12.64

2.0

39.92

39.54

u/l

0.40

1914

11732

Vitreous haemorrhage

237

1436

1.69

12.58

1.9

1.8

43.32

39.14

u/l

1.91

215

1247

Haemorrhage, not elsewhere classified

375

2.40

12.54

1.3

1.7

35.60

38.83

u/l

0.85

322

Stenosis and insufficiency of lacrimal passages

214

1263

1.73

12.52

2.2

1.9

40.54

39.64

u/l

0.26

188

1114

Other diseases of oesophagus

211

1242

1.74

12.44

2.0

1.8

39.30

39.05

u/l

0.06

189

1075

Unspecific neurodegenerative disorder

449

4369

0.70

12.41

1.6

1.7

37.97

38.04

u/l

0.02

364

3654

Other hammer toe(s) (acquired)

349

2134

1.53

12.36

2.0

1.9

42.18

39.18

u/l

1.75

295

1842

Juvenile arthritis (FINNGEN)

109

519

2.16

12.34

2.0

2.2

40.62

39.77

u/l

0.16

100

489

Alzheimer disease

279

3180

0.64

12.32

1.5

1.6

37.75

38.16

u/l

0.12

211

2622

Fibroblastic disorders

488

3461

1.43

12.30

1.8

1.9

40.56

38.63

u/l

1.31

426

3014

Cluster headache, strict, including avohilmo

143

754

1.96

12.30

1.7

2.1

37.79

39.61

u/l

0.56

131

682

Transport accidents

1090

7445

1.27

12.27

2.0

40.90

39.08

u/l

2.10

997

6722

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

384

2608

1.50

12.27

2.1

2.0

39.64

39.26

u/l

0.14

349

2395

Macular pucker

328

2158

1.55

12.26

2.1

1.7

41.29

38.04

u/l

2.15

289

1833

Failure and rejection of transplanted organs and tissues

166

3.24

12.26

2.4

2.5

40.82

39.65

u/l

0.15

149

Moderate visual impairment, binocular

294

2.58

12.24

1.7

1.9

41.08

38.06

u/l

0.50

259

Dental pulpitis, including avohilmo

2278

12579

1.18

12.24

2.0

2.1

39.83

39.55

u/l

0.27

2066

11360

Infections with a predominantly sexual mode of transmission

913

6626

1.30

12.17

2.2

2.0

40.59

39.38

u/l

1.05

834

6118

Other and unspecified follicular disorders

115

565

2.12

12.12

2.4

2.0

39.94

39.54

u/l

0.07

109

507

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

233

1422

1.68

12.05

1.8

1.9

38.82

39.04

u/l

0.06

205

1250

Use of antiglaucoma preparations and miotics

171

957

1.83

12.05

1.8

1.7

39.05

38.78

u/l

0.06

151

817

Primary adrenocortical insufficiency

142

3.43

12.04

2.4

2.3

38.80

38.17

u/l

0.05

128

Lichen simplex chronicus

454

2.25

12.04

2.3

2.0

40.45

39.30

u/l

0.18

410

Infections with a predominantly sexual mode of transmission

709

5350

1.34

12.00

2.2

2.0

41.56

39.54

u/l

1.83

645

4923

Hydronephrosis

240

1475

1.66

12.00

1.9

1.8

37.44

39.00

u/l

0.60

219

1293

Other disorders of bladder

260

1631

1.63

11.99

1.8

36.69

38.85

u/l

1.06

234

1409

Impingement syndrome of shoulder

528

3816

1.40

11.97

2.1

2.0

41.82

39.12

u/l

2.32

463

3377

Adhesive capsulitis of shoulder

368

2491

1.50

11.96

1.9

2.0

40.89

39.17

u/l

1.02

335

2198

Myocardial infarction, without ST-elevation

801

5605

1.31

11.90

1.8

1.7

36.96

38.41

u/l

1.04

661

4775

Unstable angina pectoris

720

4293

1.34

11.75

1.8

1.7

36.70

39.26

u/l

2.60

604

3751

Chondropathies

357

2417

1.50

11.64

1.9

39.29

39.28

u/l

0.00

322

2182

Pyothorax

112

553

2.10

11.64

2.0

1.8

35.72

38.20

u/l

0.77

483

Other bursopathies

289

1871

1.57

11.63

2.3

1.9

39.02

38.90

u/l

0.03

265

1648

Gout due to impairment of renal function

130

3.51

11.61

3.0

2.1

41.75

40.19

u/l

0.21

115

Gonarthrosis, primary, with knee surgery

1243

8021

1.24

11.61

1.8

1.9

38.50

39.34

u/l

0.72

1071

6964

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

614

4546

1.36

11.60

1.7

2.1

40.70

39.49

u/l

0.68

547

4176

Other abnormal findings of blood chemistry

122

622

2.03

11.60

1.9

2.0

43.88

38.47

u/l

1.76

116

556

Pneumothorax

159

883

1.85

11.55

2.1

1.9

41.75

39.03

u/l

0.75

139

761

Other local infections of skin and subcutaneous tissue

239

1485

1.64

11.51

1.8

1.9

39.06

38.85

u/l

0.06

210

1329

Early lumbar disc prolapse, operated

241

1500

1.64

11.50

2.2

40.90

39.03

u/l

0.84

229

1404

Diseases of middle ear and mastoid

1330

8890

1.23

11.49

2.0

39.42

39.28

u/l

0.09

1199

8039

Diseases of appendix

1794

13618

1.19

11.42

2.0

39.70

39.45

u/l

0.21

1611

12225

Acute pancreatitis

428

3009

1.44

11.42

1.7

1.9

38.80

39.07

u/l

0.09

377

2623

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

417

2919

1.45

11.41

1.8

2.0

38.17

39.43

u/l

0.70

367

2638

Other meningitis

212

2.86

11.37

1.8

2.2

37.45

40.88

u/l

0.72

193

Unspecified/other endometriosis

218

1327

1.68

11.37

2.0

39.18

39.60

u/l

0.09

199

1248

Car occupant injured in other and unspecified transport accidents

426

2995

1.44

11.37

2.1

1.9

41.49

38.99

u/l

1.78

391

2720

Other and unspecified vascular occlusions

193

1138

1.73

11.36

1.9

1.7

38.04

37.91

u/l

0.03

159

968

Respiratory tuberculosis, confirmed and not-confirmed

120

611

2.02

11.36

1.8

1.9

40.02

38.41

u/l

0.40

107

528

Respiratory tuberculosis

120

611

2.02

11.36

1.8

1.9

40.02

38.41

u/l

0.40

107

528

Viral and other specified intestinal infections

594

4249

1.36

11.36

1.9

39.54

39.34

u/l

0.08

541

3898

Appendicitis, broad definition

1780

13562

1.19

11.31

2.0

39.74

39.46

u/l

0.23

1598

12170

Scoliosis

184

1072

1.75

11.30

2.1

1.9

38.91

38.71

u/l

0.04

166

969

Benign neoplasm: Ascending colon

305

2016

1.54

11.22

2.0

1.8

37.35

38.64

u/l

0.53

257

1737

Monoplegia

197

2.92

11.21

1.9

2.1

40.84

38.98

u/l

0.28

173

Excessive vomiting in pregnancy

199

1189

1.71

11.20

1.8

2.0

38.46

39.43

u/l

0.30

188

1105

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

614

4537

1.35

11.19

2.0

38.55

39.26

u/l

0.39

553

4192

Procreative management

785

5052

1.31

11.17

2.0

2.1

40.86

40.07

u/l

0.53

726

4637

Lesion of lateral popliteal nerve

126

658

1.98

11.16

2.4

2.0

39.26

38.89

u/l

0.08

113

580

Acute lymphadenitis

153

850

1.85

11.16

1.8

2.1

39.79

39.13

u/l

0.13

136

784

Nonalcoholic steatohepatitis

119

3.60

11.10

2.3

2.5

61.62

41.29

u/l

3.03

108

Benign neoplasm: Stomach

224

1386

1.65

11.03

1.9

1.8

38.32

39.09

u/l

0.22

186

1222

Peripheral arterial reconstruction

324

2174

1.51

11.01

1.7

1.6

38.45

38.00

u/l

0.13

261

1839

Myocardial infarction, strict

914

5117

1.28

10.95

1.8

36.96

39.49

u/l

2.89

752

4519

Fracture of rib(s), sternum and thoracic spine

636

4805

1.34

10.85

1.9

40.03

39.01

u/l

0.55

558

4193

Cholangitis (primary sclerosing, PSC)

144

792

1.87

10.84

1.7

1.8

40.83

38.67

u/l

0.65

127

691

Primary gonarthrosis, bilateral

1104

7634

1.25

10.83

1.8

1.9

38.76

39.37

u/l

0.45

956

6634

Periodontitis

2332

13440

1.17

10.77

1.9

2.0

39.82

39.41

u/l

0.41

2039

12016

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

5.09

10.75

1.2

3.2

33.06

42.42

u/l

1.19

Non-allergic asthma

198

1194

1.69

10.74

1.8

42.42

38.92

u/l

1.52

168

1063

Other diseases of blood and blood-forming organs

164

942

1.79

10.70

1.7

1.8

40.58

38.42

u/l

0.66

138

833

Background retinopathy and retinal vascular changes

260

2.59

10.70

2.7

2.0

40.96

38.45

u/l

0.40

230

Chronic conjunctivitis

404

2.25

10.68

2.2

40.70

39.58

u/l

0.24

356

Adult-onset Still disease

5.18

10.67

1.8

2.4

39.67

42.87

u/l

0.27

Other disorders of the musculoskeletal system and connective tissue

332

2258

1.50

10.65

1.6

1.9

39.29

39.23

u/l

0.02

294

1991

Other/unspecified enthesopathies, not elsewhere classified

190

1137

1.71

10.63

2.1

2.0

39.23

38.67

u/l

0.13

168

1010

Nummular dermatitis

183

1086

1.72

10.59

1.9

1.8

40.06

38.74

u/l

0.40

165

950

Special screening examination for other diseases and disorders

215

1326

1.64

10.59

1.9

1.8

40.05

38.93

u/l

0.36

199

1161

Disorders of myoneural junction and muscle in diseases classified elsewhere

113

3.61

10.54

2.0

2.2

44.53

40.47

u/l

0.47

101

Other specified/unspecified bacterial intestinal infections

157

896

1.80

10.48

1.8

41.89

38.72

u/l

1.04

130

789

Cholecystitis

292

1939

1.53

10.48

1.9

1.8

39.01

38.44

u/l

0.16

250

1674

Other peripheral vertigo

209

1288

1.66

10.48

1.9

1.8

39.12

39.13

u/l

0.00

180

1141

Other and unspecified local infections of skin and subcutaneous tissue

223

1397

1.63

10.44

1.8

1.9

38.76

38.84

u/l

0.02

196

1250

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

182

1082

1.72

10.43

1.7

2.0

40.34

39.29

u/l

0.34

166

998

Other or unspecified ileus, impaction or obstruction

371

2583

1.45

10.43

1.6

1.8

38.88

38.64

u/l

0.08

322

2225

Appendectomy

1548

12417

1.20

10.43

2.1

2.0

39.72

39.53

u/l

0.14

1394

11189

Chronic periodontitis, including avohilmo

2320

13433

1.16

10.39

1.9

2.0

39.86

39.41

u/l

0.45

2028

12010

Atrophic disorders of skin

330

2253

1.49

10.39

2.4

2.0

40.95

39.70

u/l

0.53

297

1997

Retinal breaks without detachment

361

2509

1.46

10.36

2.1

1.9

40.06

38.80

u/l

0.53

324

2192

Hyperkinetic disorders, excluding more controls

232

1401

1.61

10.36

1.7

2.0

38.67

39.63

u/l

0.32

208

1334

Other specified and unspecified disorders of eye and adnexa

102

509

2.08

10.35

2.3

2.1

39.76

39.67

u/l

0.02

446

Unspecified chronic bronchitis

375

2.25

10.35

1.8

2.0

35.71

37.72

u/l

0.43

318

542

3498

1.36

10.33

1.8

1.7

39.25

38.19

u/l

0.51

454

2911

Colonic or urogenital fistula

608

4601

1.34

10.32

1.9

38.95

39.02

u/l

0.03

551

4072

Diseases of tongue

146

820

1.83

10.28

1.7

2.0

39.27

39.89

u/l

0.15

132

709

Heterophoria

184

1103

1.71

10.26

2.1

2.0

39.01

39.29

u/l

0.07

171

1005

Benign neoplasm: Adrenal gland

187

1128

1.70

10.25

2.0

1.8

38.26

39.18

u/l

0.26

166

993

Endometriosis of ovary

381

2611

1.44

10.25

2.0

2.1

40.02

40.06

u/l

0.01

338

2368

COPD, hospital admissions 3, with asthma pneumonia sepsis

523

3297

1.37

10.24

1.6

1.7

36.40

38.04

u/l

1.05

439

2792

Use of other anti-dementia drugs

226

2919

0.63

10.23

1.4

1.6

35.93

38.11

u/l

0.83

173

2394

Use of memantine

226

2919

0.63

10.23

1.4

1.6

35.93

38.11

u/l

0.83

173

2394

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

856

6745

1.27

10.22

1.9

2.0

40.36

39.68

u/l

0.46

782

6175

Rare circulating lymphoid malignancy, including Hilmo

308

2.39

10.20

1.6

1.9

40.71

38.15

u/l

0.36

264

Nontoxic goitre/thyroid nodule

635

4843

1.33

10.20

1.8

2.0

40.60

39.51

u/l

0.67

564

4232

Acute appendicitis

1662

13141

1.19

10.16

2.0

39.75

39.40

u/l

0.29

1498

11821

Nonsuppurative otitis media

484

3058

1.38

10.15

1.9

1.8

39.59

39.09

u/l

0.22

435

2804

Acute appendicitis, no complications

1315

10855

1.21

10.13

2.1

40.07

39.43

u/l

0.55

1193

9824

Amenorrhoea

150

852

1.80

10.12

1.6

1.7

39.63

38.53

u/l

0.32

135

802

Other noninflammatory disorders of vulva and perineum

203

1252

1.65

10.11

2.2

2.0

38.05

39.96

u/l

0.69

180

1142

KRA_PSY_EATING, excluding more controls

164

950

1.75

10.10

1.6

2.1

39.89

39.05

u/l

0.21

147

902

Infective dermatitis

249

1614

1.57

10.06

2.0

1.9

38.03

39.07

u/l

0.34

229

1433

Otitis externa

492

3622

1.38

10.06

1.7

1.9

39.74

39.22

u/l

0.23

427

3235

Nail disorders

199

1225

1.66

10.05

2.4

1.9

40.81

39.34

u/l

0.41

185

1098

Other and unspecified glaucoma

150

857

1.79

9.97

2.0

1.7

37.85

38.88

u/l

0.24

132

727

Myopia

288

1930

1.52

9.96

2.1

2.0

38.73

39.38

u/l

0.24

263

1781

Solid cancers, helper endpoint

2025

10244

1.17

9.95

1.9

2.1

39.96

39.37

u/l

0.59

1815

9158

Degenerative diseases of the nervous system

358

3732

0.70

9.90

1.5

1.7

38.06

38.26

u/l

0.06

283

3115

Maternal care for other conditions predominantly related to pregnancy

478

3443

1.38

9.89

1.9

2.1

39.77

39.45

u/l

0.14

442

3230

DVT of lower extremities

398

2839

1.42

9.86

1.9

37.31

38.93

u/l

0.81

346

2479

Fracture of lumbar spine and pelvis

438

3169

1.40

9.85

2.0

1.8

42.30

38.56

u/l

2.73

363

2727

Dislocation, sprain and strain of joints and ligaments of knee

1436

11093

1.20

9.76

2.0

40.16

39.53

u/l

0.58

1297

10017

Dystonia

137

769

1.83

9.74

1.6

2.0

40.54

38.84

u/l

0.40

121

695

Ptosis of eyelid

234

1508

1.58

9.73

2.2

1.9

39.04

39.00

u/l

0.01

209

1309

Problems related to lifestyle

239

1549

1.57

9.67

1.6

2.0

43.68

39.01

u/l

2.29

217

1405

Other facial nerve disorders

381

2.21

9.67

1.6

2.1

38.60

39.81

u/l

0.22

336

Sequelae of cerebrovascular disease

710

4766

1.30

9.59

1.6

1.8

36.48

39.00

u/l

2.31

589

4097

Disorders of oesophagus in diseases classified elsewhere

256

2.50

9.54

1.9

38.44

37.82

u/l

0.08

214

Caries of enamel

2142

13374

1.16

9.52

2.2

2.0

40.09

39.54

u/l

0.61

1930

12034

Endometriosis of rectovaginal septum and vagina

170

1019

1.70

9.52

1.9

39.88

40.10

u/l

0.05

157

918

Simple and mucopurulent chronic bronchitis

443

2.09

9.44

1.9

2.0

39.67

38.47

u/l

0.18

376

Other blood glucose lowering drugs, excl. Insulins

327

2271

1.46

9.44

2.1

1.7

36.94

39.59

u/l

1.30

289

1967

Any dementia

427

4058

0.72

9.42

1.4

1.7

37.08

38.19

u/l

0.50

341

3402

Viral pneumonia (known virus, not influenza)

301

2.35

9.40

2.2

1.9

36.00

39.26

u/l

0.62

260

Hernia of abdominal wall

997

8111

1.24

9.40

2.0

1.9

39.29

38.90

u/l

0.24

875

7125

Panniculitis affecting regions of neck and back

472

2.06

9.39

1.7

2.1

40.64

37.72

u/l

0.83

420

Acne

217

1383

1.59

9.38

1.9

2.0

41.68

39.41

u/l

0.94

204

1299

Striking against or struck by other objects

728

5714

1.28

9.33

1.9

2.0

39.89

39.45

u/l

0.24

629

5172

Acute gastritis

165

987

1.71

9.32

1.7

1.9

39.20

39.13

u/l

0.01

148

851

Alzheimer’s disease, strict definition

209

2672

0.64

9.31

1.5

1.6

38.24

u/l

0.00

159

2211

Benign neoplasm of meninges

230

1494

1.57

9.29

1.8

1.9

37.42

39.40

u/l

0.89

197

1332

Polyarteritis nodosa

3.96

9.28

1.4

2.2

36.13

38.85

u/l

0.32

Atopic dermatitis, strict definition

650

4934

1.30

9.25

1.9

2.0

39.74

39.50

u/l

0.13

597

4559

Phobic anxiety disorders

285

1932

1.49

9.24

1.8

2.0

38.98

39.56

u/l

0.19

269

1790

Vascular disorders of the intestines

138

787

1.79

9.23

1.8

39.20

38.09

u/l

0.22

113

665

Other female pelvic inflammatory diseases

362

2576

1.43

9.18

1.9

2.0

39.78

39.52

u/l

0.09

327

2309

Algoneurodystrophy

457

2.07

9.15

1.7

2.1

38.10

38.98

u/l

0.18

418

Paraplegia, diplegia of upper limbs

280

2.39

9.14

1.5

2.1

33.21

39.39

u/l

1.57

250

Viral warts

463

3432

1.37

9.10

2.4

2.0

41.24

39.48

u/l

0.93

419

3111

Blepharochalasis

595

4573

1.32

9.09

1.8

38.76

39.25

u/l

0.23

514

3934

Postzoster neuralgia

167

2.84

9.06

2.0

2.1

44.19

39.02

u/l

0.78

148

Acute pancreatitis (for exclusion)

428

3139

1.38

9.03

1.7

1.9

38.80

39.16

u/l

0.13

377

2751

Other disorders of optic disc

168

2.84

9.00

2.2

36.85

39.76

u/l

0.42

152

Chondrocostal junction syndrome [Tietze]

501

2.00

9.00

2.0

2.1

38.16

39.22

u/l

0.18

452

Carbimazole or st.post thyroidectomy, condition for graves disease

470

3502

1.36

8.97

2.1

2.0

38.16

39.56

u/l

0.80

413

3145

Myelodysplastic syndrome

3.53

8.95

1.4

1.9

29.52

38.36

u/l

1.34

Tinnitus

518

3916

1.34

8.95

2.1

1.9

38.39

39.40

u/l

0.59

460

3450

Acute myeloid leukaemia and myelodysplastic syndromes

191

2.67

8.91

1.7

1.9

31.68

40.05

u/l

1.75

159

Drug-induced neutropenia

170

1040

1.68

8.90

1.7

1.9

40.96

38.46

u/l

0.68

156

922

Other diseases of spinal cord

394

2.13

8.89

1.9

2.1

37.21

39.16

u/l

0.50

356

N06DA Anticholinesterases

347

3824

0.71

8.88

1.5

1.6

37.79

38.17

u/l

0.10

278

3185

Use of anticholinesterases

347

3824

0.71

8.88

1.5

1.6

37.79

38.17

u/l

0.10

278

3185

Other spirochaetal diseases

685

5380

1.29

8.87

1.9

2.0

41.92

39.12

u/l

3.06

593

4771

Benign neoplasm: Cerebral meninges

211

1360

1.58

8.85

1.8

1.9

37.62

39.38

u/l

0.69

181

1215

Umbilical hernia

595

4591

1.31

8.85

2.2

1.9

39.37

38.70

u/l

0.35

529

4100

Primary open-angle glaucoma

603

4503

1.31

8.81

1.9

1.7

39.75

38.61

u/l

0.68

521

3798

Late syphilis

176

2.78

8.80

3.1

2.3

36.51

39.01

u/l

0.31

156

Other contact dermatitis

185

1157

1.63

8.80

2.0

41.22

39.50

u/l

0.51

161

1047

Congenital malformations, deformations and chromosomal abnormalities

1502

11757

1.18

8.80

1.9

2.1

38.61

39.59

u/l

1.20

1350

10651

Ulcerative colitis (strict definition, all Crohn cases excluded)

325

2288

1.44

8.77

1.8

2.0

38.88

39.31

u/l

0.15

281

2071

therapeutic use

391

2.12

8.68

2.5

2.0

40.82

39.35

u/l

0.28

341

Other specific arthropathies, wide

261

2.40

8.68

1.7

2.3

35.50

39.81

u/l

0.85

237

Superficial injury of hip and thigh

294

2034

1.46

8.67

1.6

1.8

38.46

38.76

u/l

0.09

262

1770

Olecranon bursitis

138

804

1.76

8.65

2.1

1.9

36.91

38.09

u/l

0.29

123

698

Intestinal stricture

638

4982

1.29

8.64

1.8

1.9

39.63

38.91

u/l

0.37

557

4329

Substance use, excluding alcohol

444

3299

1.36

8.63

1.6

2.1

42.74

39.31

u/l

2.34

387

3004

Other disorders of binocular movement

300

2.29

8.63

1.3

2.1

35.23

40.16

u/l

1.39

270

Diseases of peritoneum

221

1447

1.56

8.63

1.7

1.8

39.37

38.98

u/l

0.10

201

1272

Other spirochaetal diseases

674

5303

1.28

8.62

1.9

2.0

42.06

39.12

u/l

3.26

583

4704

Arthropathic psoriasis

262

1779

1.50

8.61

1.6

1.9

40.59

39.64

u/l

0.31

244

1595

Barrett oesophagus

118

659

1.84

8.60

1.8

1.9

38.62

38.95

u/l

0.06

105

565

Tubulo-interstitial nephritis, not specified as acute or chronic

142

835

1.73

8.57

1.9

1.8

36.35

39.50

u/l

1.06

123

744

Speech therapy

565

4350

1.31

8.57

1.8

1.9

39.33

39.21

u/l

0.05

496

3825

Endometriosis ASRM stages 1,2

401

2944

1.38

8.46

1.9

2.1

38.33

39.79

u/l

0.78

355

2722

Recurrent dislocation and subluxation of joint

155

937

1.69

8.45

1.6

2.0

40.39

38.88

u/l

0.51

142

866

Late syphilis

222

2.52

8.42

2.8

2.2

38.14

37.90

u/l

0.02

197

Anomalies of dental arch relationship, including avohilmo

417

2775

1.37

8.35

2.1

1.9

40.91

39.34

u/l

0.90

379

2546

Aspergillosis

114

3.23

8.34

2.0

2.3

40.24

41.15

u/l

0.09

Lyme disease

665

5249

1.28

8.31

1.9

2.0

42.05

39.13

u/l

3.17

574

4658

Spirochaetal infections, other/unspecified

670

5295

1.28

8.29

1.9

2.0

42.05

39.16

u/l

3.16

579

4696

Pneumoconiosis due to dust containing silica

7.49

8.26

2.3

1.8

49.89

42.49

u/l

0.50

Amputation

194

1245

1.58

8.26

1.9

1.7

39.14

38.30

u/l

0.21

160

1061

Osteonecrosis

145

869

1.71

8.25

1.9

1.8

39.91

39.17

u/l

0.17

128

768

Superficial injury of abdomen, lower back and pelvis

322

2289

1.43

8.24

1.7

1.9

39.37

38.80

u/l

0.20

295

2039

Other disorders of pigmentation

105

574

1.88

8.22

1.9

39.42

38.96

u/l

0.08

499

Open wound of head

1161

9360

1.20

8.22

1.9

40.83

38.92

u/l

2.12

1009

8268

Unspecified fall

1069

8748

1.21

8.21

1.9

40.59

39.11

u/l

1.44

930

7733

Type of accident

626

4912

1.29

8.19

2.1

1.9

40.98

39.18

u/l

1.08

556

4372

Tonsillectomy and adenotomy

1319

7741

1.19

8.19

2.0

2.1

39.61

39.81

u/l

0.14

1218

7144

Aortic aneurysm

436

3194

1.35

8.17

1.7

37.46

38.19

u/l

0.30

375

2722

Mental and behavioural disorders due to tobacco

204

1331

1.56

8.15

1.5

1.9

42.82

39.04

u/l

1.63

170

1190

Synovial cyst of popliteal space [Baker]

156

955

1.67

8.13

2.0

1.8

38.66

38.52

u/l

0.03

138

844

Other disorders of iris and ciliary body

327

2.19

8.13

2.3

2.0

44.03

38.31

u/l

1.24

286

Supplementary factors related to causes of morbidity and mortality classified elsewhere

670

5307

1.27

8.11

2.1

1.9

41.25

39.29

u/l

1.31

596

4726

Other and unspecified erythematous conditions

443

2.01

8.11

1.6

2.0

37.08

39.04

u/l

0.46

391

Pyoderma gangrenosum

100

3.36

8.11

1.2

2.4

37.65

40.31

u/l

0.30

Noninflammatory disorders of female genital tract

901

3659

1.24

8.10

2.0

39.67

39.71

u/l

0.02

823

3315

Suppurative and unspecified otitis media

775

5520

1.25

8.10

2.1

2.0

39.80

39.36

u/l

0.25

710

5056

Inflammatory diseases of prostate (prostatitis)

261

1792

1.48

8.09

1.8

1.9

41.71

38.37

u/l

1.59

233

1551

Acute peritonitis

140

835

1.72

8.09

1.8

1.9

39.20

38.45

u/l

0.15

127

724

Other epidermal thickening

105

577

1.87

8.09

2.2

1.9

42.17

38.56

u/l

0.88

100

506

Melanocytic naevi

639

5036

1.28

8.08

1.9

2.0

38.40

39.30

u/l

0.61

569

4513

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS